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CHAPTER 1 
IRON CHAPERONES FOR MITOCHONDRIAL IRON-SULFUR CLUSTER 
BIOSYNTHESIS AND FERRITIN IRON STORAGE 
 
 
1.1 Prelude: 
The need for transition metals spans every living organism from viruses to human 
beings.  Cells traffic several transition metals to meet their dietary demand, but the 
minerals that are absolutely required include the essential metals Fe, Zn, Cu, Mo, Co, 
Mn, Cr, V and Ni [1].  Cells can also traffic additional metals, including Cd, Hg, Au and 
Ag, however these are not required for cellular vitality and are effectively cleared out of 
the cell to prevent toxicity [2].  The complement of metals required by cells is generally 
influenced by their geochemical availability [3], and it has been estimated that 
approximately a third to a fourth of all characterized proteins require metals for function 
[2].  The unique physical and chemical properties of each metal are exploited during 
their incorporation into metalloproteins, and the coordination chemistry specific to the 
metal drives formation of the protein-metal complex.  This permits metal bound proteins 
to participate in several capacities that may be structural, catalytic or regulatory in 
nature [4].  
Although indispensible to sustain life, metals are also cytotoxic, owing to their 
ability to initiate free radical reactions that can harm cellular components.  Therefore 
metal concentrations are tightly regulated by a battery of proteins that accomplish metal 
homeostasis.  Proteins that serve in this capacity include integral membrane 
transporters, metalloregulatory sensors, diffusible metallochaperone proteins and metal 
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storage proteins.  Studies of the amount of transition metals in E. coli have shown that 
Zn & Fe are the most abundant with concentrations maintained at 0.1M, while Cu, Mn 
and Se are maintained at 0.01M and V, Co & Ni are much lower in abundance [4]. 
Protein affinities for divalent metal ions follow the Irving Williams series, beginning with 
the weakest binding to the tightest, in the following order: 
Mn2+<Fe2+<Co2+<Ni2+<Cu2+>Zn2+ [5].  In spite of the fact that higher affinity metals can 
outcompete others for protein binding sites, in most cases proteins are loaded with the 
correct metal.  Loading is accomplished by several factors including: 
A) Geometry: The metal may be inclined to bind the protein due to the availability of the 
correct ligands, the right size of metal binding site and matching charges & solvation 
energy that provide the metal bound protein with greater stability.  
B) Function: In many cases proteins attain their biologically active conformation only 
after binding the correct metal.  Often, proteins improperly loaded with the wrong metal 
exhibit an incorrect fold, exposing residues that are recognized by chaperone proteins 
that bring about insertion of the correct metal or, they may be targeted for degradation. 
C) Compartmentation of Proteins: The compartment/organelle that the protein folds 
within also influences its metal binding as the complement of proteins involved in metal 
insertion may differ between compartments.  Once folded, the metal binding site may be 
buried within the protein to prevent metal exchange with higher affinity metals. 
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D) Protein delivery by metallochaperones: Some proteins are metallated via specific 
protein-protein interactions directed by metallochaperone proteins that deliver the 
specific metal to the protein [2, 4, 6]. 
 
1.1.1 The need for metallochaperone proteins: 
Efficient and selective metal delivery is essential for proper metal homeostasis 
and this chapter specifically highlights the role of metallochaperone proteins in this 
process.  Metallochaperones are diffusible proteins that bind metal ions and escort them 
to partner proteins where they are delivered and transferred for incorporation as metal 
cofactors into the apoprotein [4].  Chaperone proteins protect the metal from 
participating in the generation of free radicals and hence protect the cell from potential 
damage caused by free radicals.  Metallochaperone proteins may operate in the cytosol 
or in a subcellular compartment and they may even be found in circulation.  As an 
example, iron chaperones described so far include the human cytosolic PCBP family of 
proteins, the mitochondrial iron chaperone protein frataxin (both of which have been 
described in the review below), and the protein transferrin that ‘chaperones’ Fe3+ in the 
blood [7].  Chaperones may activate proteins through direct metal insertion converting 
the protein into its active holoform [8].  In addition, metallochaperones may interact with 
metal import proteins from which they acquire their metal ions by specific ligand 
exchange reactions rather than by scavenging metal released into the cytosol [2].  
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It has been suggested that metal ions are always in the bound form inside the 
cell.  Metals are believed to be either bound to proteins or nucleic acids and other small 
molecules such that the availability of free metal ions within the cell is far too low for 
apoproteins to directly acquire them via passive diffusion.  Their concentrations are also 
reported to be ‘buffered’ keeping the amount of metal constant.  For example, in case of 
high affinity metals such as Cu & Zn, the pool of ‘free’ Cu has been reported to be about 
one free ion per cell.  Zn efflux pumps are activated when the intracellular Zn 
concentration reaches 0.5 fM, which corresponds to about one free Zn ion per cell.  
Under such stringent conditions, cells employ metallochaperone proteins that can 
incorporate metals using atypical coordination chemistry such that metals are bound 
with a high affinity, yet can be delivered to recipients via specific protein-protein 
interactions [4].  However, exchangeable cellular metal pools have also been described 
for lower affinity metals like iron [6]. How these pools are maintained to achieve metal 
homeostasis is currently under investigation. 
The first chapter of my dissertation is a review that specifically outlines iron 
homeostasis in health & disease.  This chapter provides in-depth insight into the 
structure-function role of the iron metallochaperone frataxin, that operates in the 
mitochondria & potentially serves as a source of iron for heme and iron-sulfur cluster 
biogenesis, and the PCBP family of proteins, that operate in the cytosol and serve as 
chaperones to Ferritin and other proteins.  As my dissertation work is focused on the 
Fe-S assembly pathway, this review provides the necessary background information 
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regarding metal delivery for Fe-S cluster bioassembly and relates to the chapters that 
follow.  The bulk of this chapter been published in the following review: Subramanian, 
P., Rodrigues, A.V., Ghimire-Rijal, S. and Stemmler, T.L. “Iron chaperones for 
mitochondrial Fe-S cluster biosynthesis and ferritin iron storage” Curr. Opin. Chem. 
Biol., 2011 15(2): 312-318. 
 
1.2 Abstract: 
Protein controlled iron homeostasis is essential for maintaining appropriate levels 
and availability of metal within cells.  Recently, two iron chaperones have been 
discovered that direct metal within two unique pathways: 1) mitochondrial iron-sulfur 
(Fe-S) cluster assembly and 2) within the ferritin iron storage system.  Although 
structural and functional details describing how these iron chaperones operate are 
emerging, both share similar iron binding affinities and metal-ligand site structures that 
enable them to bind and release Fe2+ to specific protein partners.  Molecular details 
related to iron binding and delivery by these chaperones will be explored within this 
review. 
 
1.3 Introduction:  
Iron is essential for life and its unique chemical characteristics are often exploited 
in nature to assist cells in performing inherently complex oxidation chemistry, promote 
oxygen transport/storage and drive electron transfer pathways [9].  Iron is typically 
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absorbed into the body through diet [10] and on average, humans absorb 1 to 2 mg of 
iron from diet each day [11].   Although the amount of iron abstracted from the diet is 
low, tight regulation of absorbed iron is critical, as humans have no physiologic pathway 
to excrete metal.  Once consumed, over 60% of the iron is incorporated into hemoglobin 
through developing erythroid precursors and finally into mature red blood cells.  A 
second and third possible fate for Fe includes being directed towards the iron storage 
protein ferritin or being transferred throughout the body for incorporation into 
metalloprotein iron cofactor sites.  As a cofactor, Fe is often found associated within 
iron-sulfur (Fe-S) clusters, found as mononuclear Fe-S, 2Fe-2S, 4Fe-4S and other 
higher nuclearity clusters common to nature [12].  Given the body’s need to absorb and 
maintain appropriate iron levels, Fe reuse and recycling from degraded sources is 
another method the body uses to maintain iron homeostasis.  A simple breakdown in 
any of these pathways can lead to conditions that are detrimental to human health.  
When maintained at balanced levels, iron is essential for cellular and organism 
viability, however excess is toxic and deficiency leads to a variety of physiological and 
developmental irregularities[11].   Disorders related to a breakdown in iron homeostasis 
are among the most common human diseases.  Diseases of iron overload are highly 
prevalent, with the hepatological disorder hereditary hemochromatosis being one of the 
most common [13].  Hemochromatosis patients absorb two to three times more iron 
than normal dietary iron levels.  Excess iron is often deposited in the liver and redox 
chemistry performed by unregulated metal can kill the cell/organism.  Neuronal iron 
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accumulation is a phenotype of numerous neurodegenerative disorders (Parkinson’s 
disease, Alzheimer’s disease, Friedreich’s ataxia, others).  In these disorders, 
unregulated but redox active metal is pooled within specific regions of the brain 
generating oxidative stress through iron produced reactive oxygen species (ROS) 
formation [14].  ROS can damage membrane phospholipids and generate reactive 
aldehydes that damage proteins, leading to accumulation of misfolded protein 
aggregates.  While examples of the toxic effects of iron overload are prevalent, iron 
deficiency is an even larger human health issue affecting billions [15].  While iron 
deficiency leads to decreased cognitive development in children [16], continual long-
term deficiency leads to numerous other health related issues [11].  It is clear that 
biological pathways controlling iron reactivity are essential, however it is equally clear 
that pathways ensuring metal delivery occurs are equally important for maintaining cell 
viability.   
Many pathways that regulate cellular iron homeostasis are controlled at the 
genetic and at the protein level [17, 18].  As outlined in the transferrin cycle, iron is 
imported through endocytosis of Fe3+ loaded transferrin (Tf) interacting with the 
transferrin receptor (Tf-R), in a tightly regulated feedback loop controlled at the genetic 
and protein level (Figure 1.1).  In eukaryotes, iron can be diverted to the mitochondria 
where it can be utilized during heme production or during Fe-S cluster assembly 
(pathway #1 in Figure 1.1).  During mitochondrial Fe-S cluster assembly, the ISC 
machinery proteins work together to form clusters that can be loaded onto apo-
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mitochondrial proteins or pumped out of the mitochondria in some manner (labeled X) to 
be used by the cytosolic Fe-S cluster assembly machinery (CIA).  Cytosolic iron can 
also be directed for storage into ferritin in an inert form for future use (pathway #2 in 
Figure 1).  While there are obviously other fates for cellular iron, recently two iron 
chaperones have been discovered that control iron delivery in the pathways highlighted 
above.  An overview of the structure and biophysical properties leading to iron binding 
by these two chaperones is the basis of this review.  
 
1.4 Fe-S cluster biosynthesis iron chaperones: 
In eukaryotes, the mitochondrial ISC assembly is the major pathway for Fe-S 
cluster production.  Key players in the yeast ISC machinery include the assembly 
scaffold protein (either Isu1 or 2, for clarity we will refer to only Isu1), the cysteine 
desulfurase (Nfs1) that provides sulfur to Isu1, the accessory protein (Isd11) that works 
in complex with Nfs1, a ferredoxin (Yah1) working with a ferredoxin reductase (Arh1) to 
provide electrons for the reaction, and the putative iron chaperone protein frataxin 
(Yfh1) [19].  Protein orthologs are highly conserved and found in all eukaryotes, while in 
prokaryotes most are found within the ISC pathway while variants of these proteins exist 
within the sulfur mobilization (SUF) and the nitrogen fixation (NIF) assembly pathways 
[20].  Isu1 is one of the most conserved proteins [21, 22], containing three conserved 
cysteines critical for de novo Fe-S cluster assembly [23, 24].  Sulfur transfer between 
Nfs1 and Isu1 occurs as a persulfide (-SSH) through a direct interaction between  
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Figure 1.1:  Major pathways for iron incorporation/utilization within a cell.  Two 
pathways for Fe2+ utilization highlighted within the review include: 1) Frataxin and its 
role in mitochondrial Fe-S cluster assembly via the ISC-Machinery (* including the 
cysteine desulfurase/Isd11 complex that provides sulfur); 2) PCBP and its role in 
ferritin associated iron storage. 	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partners [25]; insight into the nature of this interaction has come from a recent structural 
characterization of bacterial orthologs [26].  In vivo, Yfh1 is essential for Fe-S cluster 
maturation [27], and an interaction between Yfh1 and Isu1/Nfs1/Isd11 is critical for 
cluster biosynthesis [28].  In vitro, frataxin was shown to deliver iron to the scaffold 
protein to stimulate Fe-S cluster assembly [29].  Based on these and additional reports 
(see review [19]), frataxin was shown to play a direct role in mitochondrial Fe-S cluster 
assembly, possibly by serving as the iron chaperone[28, 30], deficiency of which has 
direct consequences regarding cellular oxidative stress [31].    
Insight into frataxin’s function has come from investigating the structure and iron 
binding abilities of numerous orthologs [32].  Frataxin is a member of the a-b sandwich 
motif family, with N- and C-terminal helices constructing one molecular plane and the 
second constructed by at least five anti-parallel b-strands [33-38].  Key structural 
features for the frataxin orthologs include highly conserved surface exposed acidic 
residues lining the helix-1/strand-1 junction, a short predominately unstructured N-
terminal region in eukaryotic orthologs only, and a C-terminal region in the human and 
bacterial proteins that confer stability [39].  The iron binding ability of frataxin was first 
identified in the yeast ortholog associated with iron induced aggregation stabilized by 
low salt/high oxygen solution conditions [40].  Monomeric bacterial, yeast, fly and 
human frataxin have since been shown to bind iron with micromolar affinity [29, 36, 41-
44], and in vivo mutations preventing Yfh1 aggregation show no Fe-S cluster 
phenotypes under normal growth conditions [45], indicating while protein aggregation 
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may be important under oxidative stress, monomeric frataxin is active during Fe-S 
cluster assembly.  Experimental data verify conserved acidic residues on frataxin’s 
helix-1/strand-1 junction are directly involved in iron binding [36, 41, 43].  Structural 
studies confirm monomeric frataxin binds high spin Fe2+ in a symmetric 6-coordinate 
ligand environment constructed of only oxygen and nitrogen ligands, in agreement with 
the conserved acidic residue identified by NMR as iron ligands [43, 44, 46].  These data 
suggest as a starting point for iron delivery, frataxin binds iron using carboxylate side 
chain oxygens from conserved Asp and Glu residues from the helix-1/strand-1 iron 
binding sites, most likely with assistance from water molecules.  Binding in this manner 
would predispose iron for delivery to Isu1 (Figure 2) since the exposed metal would be 
positioned for delivery to the protein partner and the charged surface surrounding the 
metal would be amenable for forming an interaction with a complementary charged 
region of the protein partner. 
Yfh1 undergoes an iron-stimulated interaction with Isu1/Nfs1 [28, 47, 48] in 
agreement with frataxin interacting directly with members of the ISC assembly 
machinery.  In vivo mutational studies place frataxin’s acidic helix-1/strand-1 ridge, with 
residues on the Yfh1 β-sheet surface, as interacting with Isu1 [47-51].  In vitro binding 
interactions show frataxin/scaffold binding is iron dependent and occurs at nM binding 
affinity [44, 52, 53].  Chemical shift mapping studies provide spectroscopic confirmation 
that Isu1 interacts with Yfh1 on frataxin’s acidic helix-1/strand-1 ridge utilizing the 
protein’s β-sheet surface, in close agreement with in vivo mutational analysis [53].  In 
eukaryotic systems, activity assays for Fe-S cluster production confirm iron loaded 
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frataxin stimulates in vitro Fe-S cluster assembly, possibly by delivering the Fe2+ 
required for cluster production [29, 44, 54].  Direct structural details of the 
frataxin/scaffold interaction are however lacking.  Two recent structural papers shed 
light on the potential binding interaction between these protein partners.  
Crystallographic data on the Aquifex aeolicus IscU ortholog, with cluster bound, confirm 
the three conserved Cys residues implicated in assembly form the active site of IscU 
[55].  An even more exciting result comes from the structure of the bacterial cysteine 
desulfurase (IscS) in complex with IscU [26].  This structure shows IscU binds to IscS 
such that the IscU Cys active site is in close contact with the IscS Cys residue 
implicated in forming the persulfide used for sulfur transfer.  Binding of Isu1 to Nfs1 in 
this manner would prevent frataxin from interacting in this region, assuming sulfur 
delivery happens before iron delivery.  Irrespective of this assumption, mounting 
evidence suggests all proteins in the ISC machinery form a complex that promotes the 
formation of a stable macromolecular complex used to accomplish cluster assembly, so 
the frataxin piece of this puzzle would need to fit in a unique location on Isu1.  A likely 
candidate for where Yfh1 could bind to Isu1 is on the scaffold protein’s C-terminal helix 
(Figure 1.2) [53].  The charge distribution from the electrostatic potential surface of Isu1 
in this region matches nicely to the Yfh1 b-sheet surface.  Conserved acidic/basic 
residues on Isu1’s C-terminal helix could serve as the initial Fe2+ binding residues, metal 
could then translocate to the scaffold’s active site [53].  Positional orientation of bacterial 
frataxin on the IscS/U from small angle X-ray scattering studies [56] suggest that such 
an orientation may be possible, although this orientation is likely to be altered between  
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Figure 1.2: Molecular details of the 2 Fe2+ binding sites on Yfh1 (PDB #2GA5), 
and the Cys rich active site on Isu1 (modeled structure) coupled with possible 
Isu1 Fe2+ binding sites on the protein’s C-terminus.  Ferrous iron (blue dots) shown 
with arrow denoting Fe transfer events between the two proteins. 	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the prokaryotic and eukaryotic orthologs since the accessory protein Isd11 found only in 
eukaryotes is likely also positioned in this region. Following Fe delivery to Isu1 by Yfh1, 
the binding energetics are reduced, frataxin dissociates from its partner and Isu1 is 
primed for delivery of the second Fe atom required to make a 2Fe-2S cluster. 
Recently it has been suggested frataxin may participate in Fe-S cluster 
biosynthesis by regulating activity of the cysteine desulfurase.  NMR mapping studies of 
bacterial frataxin (CyaY) onto the bacterial IscS suggest residues lining frataxin’s b-
sheet ridge tangential to the C-terminus of helix 1, with helix-1 residues, participate in 
IscS binding [57].  Mutagenesis and binding studies implicate a region on one IscS 
monomer, in proximity to the persulfide site in the second molecule in the dimer, as the 
CyaY binding surface on IscS [26].  Recent studies suggest CyaY acts as an iron-
dependent inhibitor of cluster formation by negatively regulating IscS activity [57].  In 
contrast, another recent report suggests human frataxin acts as an allosteric activator of 
Nfs1 [58].  Regardless, binding of frataxin to the ISC machinery is important during 
assembly and it will be interesting to see how this binding is finally correlated to iron 
delivery and assembly. 
 
1.5 Ferritin iron chaperones  
Cellular pathways directing iron storage are essential for preventing iron toxicity 
during overload and ensuring availability during deficiency.  Storage is directed by the 4-
helix bundle protein ferritin [59].  Mammalian cytoplasmic ferritins exist as a 24 subunits 
multimer of 2 ferritin subunit:  H chain (21,000 kDa), which controls the ferroxidase 
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chemistry coupled to iron storage, and the L chain (19,000 kDa).  Apo-ferritin H and L 
chains self-assemble to form a spherical protein shell that stores up to 4500 iron atoms 
as ferroxyhydrite within the central cavity.  Iron storage involves two key steps: iron 
oxidation, leading to formation of a μ-oxo(hydroxo)-bridged di-Fe(III) intermediate, and 
mineralization, depositing the intermediate as inert  ferrihydrite mineral.  To proceed, 
iron must first be delivered to ferritin, and ferrous iron delivery occurs at a ferritin 
oligomer hydrophilic threefold (iron entry) channel.  H-chain surface exposed residues 
H118 [60] and C130 [61], with threefold channel funnel-like forming residues Asp131 
and Glu134 [62], are used during iron import.  Binding of an iron chaperone must 
therefore proceed through direct contact with ferritin’s three-fold iron entry site (Figure 
1.3). 
Recently, the human poly (rC)-binding protein (PCBP) was shown to function as 
a cytosolic iron chaperone that delivers Fe2+ to ferritin [63].  The RNA-binding PCBP 
protein family was originally shown to be important in mRNA stabilization and 
translational activation/silencing [64].  PCBPs have 3 KH (hnRNP K homology) 
domains, with structures of the two N-terminal domains and the third domain of PCBP2 
being characterized [65, 66].  Expression of human PCBP1 recovered an iron loading 
deficiency for human ferritin expressed in yeast [63].  PCBP1 binds to ferritin in vivo and 
in vitro facilitates iron loading.  PCBP1 binds 3 iron atoms at mM binding affinity 
comparable to frataxin’s iron affinity [32].  Metal binding sites on PCBP are unknown, 
however recent iron structural data indicate PCBP1/2 bind ferrous iron in a 6-coordinate 
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Figure 1.3:  Structural details of PCBP as a ferritin iron chaperone.  Top Right: 
PCBP2 total projected structure based on domains 1,2 (PDB #2JZX) and domain 3 
(PDB #2P2R) structure linked together for visual clarity associated with 3 bound 
iron atoms (blue dots).  Top Left: structure of the human  ferritin 24-mer (PDB 
#3AJO) with iron loaded (blue dot) trimeric symmetry center.  Bottom Left: 
expansion of the ferritin trimeric interface with residues from three subunits involved 
in Fe2+ loading (H118 and C130). In addition, residues (D131, E134) on the inner 
side of the iron incorporation gate that support metal exchange are also given. 	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oxygen/nitrogen ligand environment (author’s unpublished results).  Although molecular 
details of PCBP as an iron chaperone are still emerging, it is interesting to note that 
thermodynamic and structural data regarding PCBP iron binding are so similar to that of 
the Fe-S assembly iron chaperone. 
 
1.6 Conclusions 
Evidence that frataxin and PCBP are iron chaperones is compelling, although 
clarification of their function at the genetic, molecular and atomic levels will be important 
for understanding how they operate.  There are still many questions that remain 
regarding the identity of other chaperones, how iron is loaded onto a chaperone and 
what promotes chaperone metal specificity?  A possible candidate for the first question 
is the Glutaredoxins Grx3/ 4, members of the thioredoxin (Trx) fold family.  Grx3/4 are 
central for cellular iron trafficking and a strong dependence of iron binding for Grx3/4 on 
core components in the ISC pathway indicate Grx3/4 bind iron as a Fe-S cluster [67].  
The ability to form a bridging 2Fe-2S cluster with Fra1/2 for activation of Aft1 [68], 
coupled with the direct dependence of Grx3/4 on iron loading into heme, Fe-S clusters, 
into ribonucleotide reductase, etc. suggest iron activated by Grx3/4 may be utilized by 
other dedicated assembly factors [67].  Frataxin and PCBP are most likely the start of a 
soon to be recognized long list of iron chaperones. 
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CHAPTER 2 
IRON BINDING AND INITIAL METAL LOADING SITE ON THE ISU SCAFFOLD 
PROTEINS 
 
 
2.1 Prelude  
The iron-sulfur (Fe-S) cluster scaffold protein, ISU drives the chemistry 
associated with mitochondrial Fe-S cluster assembly.  This process is accomplished by 
an interaction of ISU with several protein partners, stimulating the process of ferrous 
iron delivery and sulfide delivery in the process.  One of our early goals was to take an 
individual molecular approach to understand how cluster assembly is accomplished.  
Given the importance of ISU in the assembly process, we would like to deconstruct the 
substrate delivery events with the cluster assembly events in a step-wise manner, with 
the hope of determining mechanistic details that lead to the assembly process.  
Therefore, we began by looking at the iron loading events for how ISU is initially 
exposed to substrate.  To accomplish this, we did a comprehensive characterization of 
ISU iron loading events.   
The work described below, which is directed to accomplish this aim, was 
performed on four ISU orthologs:  human, fly, yeast and bacteria.  This work was 
initiated by previous graduate students in the Stemmler laboratory: Dr. Jeremy Cook 
and Dr. Swati Rawat, in collaboration with the Cowan laboratory (Ohio State) and the 
Lindahl laboratory (Texas A&M).  Saccharomyces cerevisiae Isu1 (or YIsu1) used in 
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these studies was a variant that contained a D37A mutant that locked the synthesized 
cluster in place while the complementary experiments were performed on the wild type 
ISU orthologs.  My goal was therefore to complete the complementary experiments on 
the wild type (WT) Sc Isu1 protein, to set the basis for comparison of orthologs under 
similar conditions.  I have optimized expression & purification of the WT Sc Isu1 
ortholog, and characterized the protein in detail in this and the subsequent chapter.   
 
2.2 Abstract 
Fe-S clusters are utilized in nearly every biochemical pathway.  The chemistry of 
iron is modulated by incorporation of metal into Fe-S clusters, protein bound cofactors 
that drive biochemical pathways ranging from steroid biosynthesis to energy production. 
In eukaryotes, clusters are assembled by the Isu scaffold protein.  The iron-sulfur (Fe-S) 
scaffold protein ISU occurs ubiquitously among all organisms.  The ISU proteins have 
three conserved cysteine residues in the active site that coordinate iron and sulfur 
during the synthesis of a cluster.  The source of sulfur for cluster assembly is the protein 
cysteine desulfurase that catalyzes the conversion of cysteine to alanine forming an 
active persulfide that appears to be transferred directly to ISU’s active site. Frataxin, a 
potential mitochondrial iron chaperone protein, has been identified to provide the 
putative source of iron, however, the region of binding and/or delivery of iron onto ISU 
remains unknown.  In this study the ISU iron binding properties of four orthologs 
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(human, fly, yeast and bacteria) have been characterized and compared to identify 
unifying factors for iron utilization.  Isothermal titration calorimetry studies show ISU can 
bind iron alone with a nano- to micromolar binding affinity.  X-ray absorption 
spectroscopy results show that the Fe(ll)-ISU complex is composed of a ligand 
environment that is completely oxygen/nitrogen based in all orthologs, indicating Isu 
binds iron at a site distinct from its cysteine rich active site.  Mössbauer spectroscopy 
confirmed the iron-oxygen/nitrogen ligand environment at this metal “acceptance” site.  
In addition to identifying a unique iron-binding site on ISU, a model for Fe delivery to ISU 
has been proposed. 
 
2.3 Introduction 
 
In the pre-biotic milieu of ancient earth, Fe-S clusters were most likely among the 
first chemical compounds to perform the chemistry essential to life processes [1].  Fe-S 
cofactors are used ubiquitously throughout biology to perform basic catalytic, electron 
transfer, and regulatory roles [2, 3].  Three dedicated pathways and upwards of at least 
20 different proteins have been identified for the formation of these ancient cofactors [4].  
The major pathway within the mitochondria responsible for general Fe-S cluster 
production is the iron-sulfur cluster (ISC) biosynthetic pathway [4].  Assembly of Fe-S 
clusters within the ISC pathway requires a highly conserved scaffold protein on which 
the cofactors are assembled (termed ISU or IscU in eukaryotes and prokaryotes, 
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respectively) [5-8].  Sulfide is provided by a cysteine desulfurase, NifS (along with an 
accessory protein, Isd11 in eukaryotes) [4, 6, 9].  Frataxin, a chaperone protein, is 
believed to be the putative iron donor [6, 10-14].  Although genetics studies have 
identified many of the players involved during assembly, many biochemical details of the 
pathway are still unclear.  ISU proteins contain three highly conserved cysteine residues 
and a semiconserved histidine residue; in the active site [15, 16].  This finding was 
recently validated in prokaryotes by the crystal structure of IscU with a 2Fe-2S cluster 
bound [17].  However, the enzymatic mechanism for Fe-S cluster production remains 
unknown.  In this report, we seek to characterize four highly homologous ISU orthologs 
(Homo sapiens, Drosophila melanogaster, Saccharomyces cerevisiae and Thermatoga 
maritima) in the hope of clarifying the initial steps of Fe binding to ISU proteins.  Isu 
proteins studied in this report exhibit 80% (Dm), 73% (Sc), and 28% (Tm) sequence 
identity to the human homolog (Figure 2.1).  We present both structural and 
biochemical data that suggest the presence of a metal binding site on the protein 
independent of the active site in each of the ISU proteins. 
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2.4 Materials and Methods: 
2.4.1 Protein Expression and Purification 
S. cerevisiae Isu1 containing a D37A mutation was subcloned into a pET21b 
expression vector (Novagen) with a C-terminal His tag and the sequence was confirmed 
by DNA sequencing.  Plasmid was transfected into BL21(DE3) CodonPlus cells and 
grown by auto induction [18] at 25°C for ca. 24 hrs. before harvesting by centrifugation 
(5000 rpm, 45 min).  All protein isolation steps were all performed at 4°C.  Cells were re-
suspended in 50 mM NaPO4 (pH 7.5), 300 mM NaCl, 20 mM Imidazole, and 5 mM β-Me 
(5 mL/g cells) in the presence of Complete EDTA free protease inhibitor cocktail 
(Roche).  Cells were lysed during two passes through a French press cell followed by 2 
rounds of sonication (50% power), and spun at high speed (21000 rpm) for 1 hour.  The 
crude soluble fraction was filtered (0.20 μm) and loaded onto a HisPrep FF Ni-column 
(Pharmacia) using an Imidazole gradient (20-500 mM, protein elutes ~ 120 mM).  Active 
fractions were pooled and concentrated to ca. 1 mL using 3 kDa cutoff centricons 
(Millipore) and run over a Sephadex 75 size exclusion column (Pharmacia) equilibrated 
with 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me.  The protein eluted as a 
dimer at ≥ 95% purity (typical yields were 1 mg/L).  D. melanogaster mature wild type 
ISU was subcloned into a pET151D-TOPO expression vector (Invitrogen) with cleavable 
His-tag and then sequenced.  Plasmid was transfected into BL21(DE3) CodonPlus cells 
and grown by auto induction [18] at 25°C for ca. 24 hrs. before harvesting by 
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centrifugation.  Protein was isolated as described above with typical yields of 27 mg/L.  
The plasmid containing the Sc Isu1 WT gene was transformed into BL21 codon plus RIL 
cells (Stratagene) for protein expression.  Cells were grown at 370C in Luria-Bertani 
broth containing Ampicillin (0.1 μg/ μl) and Chloramphenicol (0.05 μg/ μl) with shaking 
speed set at 250rpm.  At OD600 of 0.6 cells were induced for protein expression by the 
addition of 0.8mM IPTG.  Post induction expression conditions were found to be 
optimum at a temperature of 370C, over a period of 3 hrs. following which the cells were 
harvested by centrifugation and stored at -800C until lysis.  Protein purification followed 
methods similar to those described above.  Wild type Sc Isu1 eluted as a dimer.  Pure 
fractions were pooled and protein concentration was determined using IR Spectrometry 
(EMD Millipore Direct Detect).  Purification yielded about 2.5 mg/ml of ≥ 95% pure 
protein from ~ 50gm cells.  Purified samples of the H. sapien and T. maritima orthologs 
were generously provided by the Cowan lab (Evans Laboratory of Chemistry, Ohio State 
University), expression and isolation protocols are described elsewhere [10, 12, 19]. 
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Figure 2.1.  Sequence alignment of ISU proteins.  Mature protein sequences from H. 
sapiens, D. melanogaster, S. cerevisiae and T. maritima were aligned using Kalign v2 
software [20]. The conserved 3-Cysteine active site consists of C71, C98 and C159 
according to the consensus ruler. 
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2.4.2 Isothermal Titration Calorimetry experiments & analysis: 
Isothermal titration calorimetry (ITC) measurements were performed to measure 
the binding affinity and maximum stoichiometries of ferrous iron to each ISU protein. 
Experiments were performed at 30 °C on a VP-ITC titration microcalorimeter (Micro Cal 
Inc.).  A solution containing 30 μM ISU (human, yeast and Thermatoga) was thoroughly 
degassed and loaded into the adiabatic cell and 500 μM buffered anaerobic ferrous iron 
solution was loaded into the syringe.  The Fe into Dm Isu ITC experiment was 
conducted by titrating a 2.1 mM ferrous iron solution into 90 µM DIsu solution in small 
increments.  An initial 2 μL injection was followed by 29 additional injections of 10 μL 
titrant allowing 10 min between each injection to allow for complete equilibration with 
constant stirring (500 rpm).  Both sample and titrant were in matched 20 mM HEPES 
(pH 7.5), 150 mM NaCl and 5mM β-Me buffer.  Data was collected in duplicate and 
protein samples were extensively degassed and buffers were purged with Ar (g) to help 
stabilize the iron in the ferrous state.  Data was fit and analyzed using the Origin 5.0 
software package supplied by Micro Cal (GE life sciences), which uses a non-linear 
least squares curve fitting algorithm, to determine the stoichiometric ratio, dissociation 
constant and change in enthalpy of the reaction. 
Experimental parameters for the WT Sc Isu1 to Fe (ll) titration was similar as 
described above.  A 1 mM solution of Fe (ll) was titrated into 50 µM solution of WT Sc 
Isu1 protein.  Both solutions were prepared in the same buffer, which contained 20 mM, 
HEPES (pH: 7.5), 150 mM NaCl, 5 mM β-ME.  The parameters of the ITC experiment 
are the same as described above. 
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2.4.3 XAS Sample Preparation and Analysis 
X-ray absorption spectroscopy (XAS) was used to study the electronic properties 
and ligand coordination geometry of iron bound to different ISU orthologs.  All samples 
were prepared anaerobically within a glove box (PlasLabs) using protein and iron 
solutions that were initially degassed on a Schlenk line and stored under an Ar(g) 
atmosphere. XAS samples were prepared at ~0.5 mM final protein concentrations in 20 
mM HEPES (pH 7.0), 150 mM NaCl and 5 mM β-Me buffer.  WT Sc Isu1 samples were 
prepared as described above in buffer containing 20 mM HEPES (pH: 7.5), 250 mM 
NaBr, 5 mM β-Me.  Samples were diluted with 30% glycerol as a glassing agent and 
loaded into Lucite cells wrapped with Kapton tape, flash frozen in liquid nitrogen, 
removed from the glove box and stored in liquid nitrogen until data collection.  
XAS data were collected at the Stanford Synchrotron Radiation Laboratory 
(SSRL), on beamlines 7-3 and 9-3, and at the National Synchrotron Light Source 
(NSLS), on beamline X3b.  Beamlines were equipped with harmonic rejection mirrors 
and either Si(220) double crystal monochromators or a Si(111) single crystal 
monochromator, at SSRL and NSLS, respectively.  Samples were maintained at 10 K 
using an Oxford Instruments continuous-flow liquid helium cryostats at SSRL and at ca. 
24 K using a He Displex Cryostat at NSLS.  Protein fluorescence excitation spectra 
were collected using 30-element Ge solid-state array detectors at SSRL and a 13- 
element Ge solid-state detector at NSLS.  XAS spectra were measured using 5 eV 
steps in the pre-edge regions (6900-7094), 0.25 eV steps in the edge regions (7095- 
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7135 eV) and 0.05 Å-1 increments in the extended X-ray absorption fine structure 
(EXAFS) region (to k = 13.5 Å-1), integrating from 1 to 20 s in a k3 weighted manner for 
a total scan length of approximately 40 minutes.  X-ray energies were calibrated by 
collecting an iron foil absorption spectrum simultaneously with collection of the protein 
and model data.  The first inflection point for the Fe foil edge was assigned at 7111.3 
eV. Fluorescence channels for each scan was examined for spectral anomalies prior to 
averaging and spectra were closely monitored for photoreduction. 
SSRL protein data represent the average of 5 to 6 scans, while NSLS protein 
data represent the average of 8 to 9 scans.  XAS data were processed using the 
Macintosh OS X version of the EXAFSPAK program suite integrated with the Feff v7.2 
software for theoretical model generation [21].  XAS data reduction utilized a Gaussian 
function in the pre-edge region and a three-region cubic spline in the x-ray absorption 
fine structure (EXAFS) region.  EXAFS data were converted to k-space using an E0 
value of 7130 eV.  The k3 weighted EXAFS was truncated at 1.0 and 12.85 Å-1 for 
filtering purposes and Fourier transformed.  The final fitting results presented are from 
analysis of the raw unfiltered data.  
EXAFS data fitting analysis performed on both Fourier filtered and raw/unfiltered 
data gave equivalent structural results.  Model and protein EXAFS data were fit using 
both single and multiple scattering amplitude and phase functions calculated using Feff 
v7.2.  Single scattering Feff v7.2 models were calculated for carbon, oxygen, sulfur and 
iron coordination to simulate possible iron-ligand environments in our systems.  Fits to 
the crystallographically characterized model compounds were used to calibrate the 
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scale factor and ΔE0 values which we used in our protein fits.  A scale factor of 0.95 
and a threshold shift (ΔE0) -11.5 eV were used during our protein data analysis.  The 
scale factor and E0 were not allowed to vary as they were calibrated from the Fe(II) 
model compounds matching the oxidation state of the ferrous iron we found in our 
protein samples.  When simulating empirical data, metal-ligand coordination numbers 
were fixed at half-integer values while only the absorber-scatterer bond length (R) and 
Debye-Waller factor (σ2) were allowed to freely vary.  The criteria for judging the best fit 
simulation, and for adding ligand environments to the fit, included: (A) the lowest mean 
square deviation between data and fit (F’), a value corrected for number of degrees of 
freedom in the fit, (B) individual shell bond distances must be outside the spectral 
resolution (> 0.13 Å), and finally (C) all Debye-Waller factors in the ligand system must 
have values less than 0.006 s2. 
 
2.4.4 Mössbauer Spectroscopy Sample Preparation and Data Analysis 
Mössbauer samples were prepared anaerobically in a glovebox (PlasLabs), and 
all proteins and solutions were first extensively degassed on a schlenk line.  Ferric 57Fe 
was dissolved in a mixture of HCl/HNO3 and reduced to the ferrous form using sodium 
hydrosulfite in a basic solution under anaerobic conditions.  Iron oxidation state was 
confirmed using the Fe(II) specific chromophore bipyridine.  The reduced iron was 
combined with ISU protein samples at a 1:1 stoichiometry and allowed to equilibrate for 
10 min at room temperature prior to loading into the sample cells.  Samples were frozen 
in the glovebox using an aluminum block bathed in liquid nitrogen.  Mössbauer spectra 
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were also collected at Texas A&M University using a model MS4 WRC spectrometer 
(WEB Research, Edina, MN) with a 4.5 to 300 K closed-cycle helium refrigerated 
system and a W106 temperature controller.  Data was analyzed using the WMOSS 
software package (WEB Research, Edina, MN).  Isomer shifts are quoted relative to Fe 
metal at 298 K.  Spectra were collected for 24 h at 4.5 K and 100 K with little 
distinguishable difference in spectral features. 
 
2.5 Results 
2.5.1 ISU Proteins Directly Bind Iron 
In order for the protein-assisted assembly of Fe-S clusters to occur within the ISC 
pathway, ISU proteins must be capable of binding iron.  Using ITC, we observed ISU 
proteins have a direct interaction with ferrous iron.  It has been previously shown the Tm 
and Hs proteins are capable of binding ferrous iron at micromolar binding affinities [12, 
15].  We observe similar results in the two additional species; Dm and Sc (D37A). 
Measurements of both Dm and Sc ISU were performed anaerobically in buffered 
solutions that helped increase protein stability (20 mM HEPES (pH 7.5), 150 mM NaCl 
and 5 mM β-Me).  Addition of iron resulted in a strong single exothermic reaction shown 
in Figure 2.2 A, C for both Dm and Sc ISU.  Plots of the integrated heat released vs. 
molar ratio are shown in Figure 2.2 B and D for Dm and Sc ISU, respectively.  Data 
were best fit in both cases using a 2 binding-site model using the Origin 5.0 software. 
Dm Isu binds approximately 1.21± 0.25 Fe(II) atoms with an apparent KD1 of 475 ± 166 
nM and 1.40 ± 0.07 Fe(II) atoms with a KD2 of 64.5 ± 17 nM.  Sc Isu1 (D37A) binds ca.  
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Figure 2.2.  Fe(ll) binding to ISU proteins by ITC. Raw isothermal titration calorimetry 
and binding isotherm data for ferrous iron binding to ISU proteins. Raw heat released 
data for Dm ISU (A) Sc Isu1 D37A (C) and Sc Isu1 WT (E) binding to ferrous iron, 
simulated fits to the binding isotherm data for Dm Isu (B), Sc Isu1 D37A (D) and Sc Isu1 
WT (F).  Data were collected anaerobically at 30°C in 20 mM HEPES (pH 7.5) and 150 
mM NaCl and 5mM β-Me.  Spacing between injections was 10 minutes.  Syringe stirring 
speed was kept at 500 rpm. 
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Table 2.1.  Fe (II) binding affinities of ISU proteins.  ITC fitting parameters for ISU 
proteins binding ferrous iron.  Averaged values for stoichiometry (N1 and N2) and 
dissociation constants (KD1 and KD2) are provided with error bars. 
 
 
Ortholog 
 
N1 KD1 N2 KD2 
H.sapien 1.0‡ 2.0 ± 0.2 uM --- --- 
D.melanogaster 
 
1.21 ± 0.25 
 
475 ± 166 nM 
 
1.40 ± 0.07 
 
64.5 ± 17 nM 
 
S.cerevisiae 
(D37A) 1.19 ± 0.66 234 ± 35 nM 0.97 ± .31 6 ± 4 nM 
T.maritima 1.0§ 2.7uM --- --- 
S.cerevisiae 
(WT) 
 
1.61 ± 0.16 
 
0.98 ± 0.75 
uM 
 
0.6 ± 0.16 
 
18 ± 7.24 nm 
 
‡ [16] 
§ [15] 
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1.19 ± 0.66 atoms Fe(II) with a KD1 of 234 ± 35 nM and 0.97 ± 0.31 atoms Fe(II) with a 
slightly tighter KD2 of 6 ± 4 nM.  These binding affinities are slightly tighter compared to 
previously published data for Hs and Tm ISU, of which both bound Fe(II) in the μM 
range (Table 2.1); however, the Hs and Tm data were collected under different buffer 
conditions [12, 15, 16]. The WT Sc Isu1 sample, as the D37A Sc Isu1 variant bound ca. 
1.61 ± 0.16 atoms Fe (II) with a KD1 of 0.98 ± 0.75 μM and 0.6 ± 0.16 atoms Fe (II) with 
a tighter KD2 of 18 ± 7.24 nM shown in Figure 2.2 E and F. 
 
2.5.2 Iron Coordination Geometry of ISU Proteins 
 
XAS studies were used to probe the structural details of initial iron loading onto 
ISU type proteins.  Full XAS data sets were collected on multiple independent samples 
of Hs, Dm, Sc and Tm ISU proteins with one iron bound.  Samples were prepared 
anaerobically and loaded into each sample cell while the protein was inside a glove box. 
XANES analysis revealed iron was predominantly in the Fe(II) state as compared to 
ferrous iron controls, based on the analysis of the first inflection point of the edge 
feature for each spectrum.  Raw EXAFS data for all 4 ISU samples show a predominant 
single frequency pattern centered at ca. 5-6 Å-1 and this is suggestive of a nearest-
neighbor coordination environment constructed of only O/N based ligands (Figure 2.3 
A, C, E, G black lines).  An apparent ‘camel back’ feature is observed for the Hs and 
Tm samples (Figure 2.3 A and G, respectively) suggesting the presence of a Histidine 
ligand, but this feature is not present in the other samples.  Fourier transforms of the 
data for Hs, Dm, Sc and Tm ISU proteins (Figure 2.3 B, D, F, H, black lines, 
respectively) indicate a predominant single nearest neighbor ligand environment feature
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Figure 2.3.  EXAFS and Fourier transforms of iron loaded ISU XAS data.  
EXAFSspectra in black (A,C,E,G) and FT (B,D,F,H) data, and best fit simulations shown 
in green of H. sapiens (A,B) D. melanogaster (C,D), S. cerevisiae (E,F) and T. maritima 
(G,H) ISU proteins bound to 1 Fe atom. 
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Table 2.2.  Summary of EXAFS fitting results for Fe bound ISU proteins.  Data fit 
over a k range of 1 to 12.5 Å-1 using EXAFSPAK and feff7 theoretical models. 
 
 Fe-Nearest Neighbor 
Ligandsa  
Fe•••Long Range Ligandsa  
 
Sample Atomb R(Å)c C.N.d σ 2 e Atomb R(Å)c C.N.d σ 2 e F’ f 
H.sapien O/N 2.01 1.5 2.02 C 3.13 3.0 5.83 0.45 
 O/N 2.14 4.0 1.28 C 3.52 1.0 1.0  
     C 4.13 6.5 5.95  
          
D.melanogaster O/N 1.99 3.0 3.78 C 3.13 1.5 3.01 0.32 
 O/N 2.15 2.0 2.94      
          
S.cerevisiae O/N 2.01 1.0 1.91 C 3.01 1.5 1.14 0.99 
 O/N 2.14 4.5 3.25      
          
T.maritima O/N 2.13 6.0 4.30 C 3.10 3 1.56 0.99 
     C 3.27 4.5 1.20  
     C 3.49 4.5 1.66  
     C 3.71 3.5 3.9  
 
a Data were fit over a k range of 1 to 12.5 Å-1.   
b Independent metal-ligand scattering environment 
c Scattering atoms: O (oxygen), N (nitrogen), S (sulfur) and C (carbon),  
d Average metal-ligand bond length from two independent samples 
e Average metal-ligand coordination number from two independent samples 
f Average Debye-Waller factor in Å2 x 103 from two independent sample 
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centered around a phase-shifted bond length (R + Δ) of ca. 1.8 Å, with minimal 
scattering from long distance ligands.  Hs, Dm, and Sc data were best fit using 2 O/N 
shell nearest neighbor simulations (Figure 2.3 A, C, E, green lines) while Tm samples 
could only be fit using a single O/N shell (Figure 2.3 F).  Long-range scattering could 
only be fit with carbon scattering, attempts with fits using sulfur or iron atoms decreased 
the quality of the fit. The best-fit simulations are summarized in Table 2.2.  All samples 
show partially disordered ligand environments with total coordination around 6, as would 
be expected for an Fe(II) with octahedral symmetry.  Interestingly, there is no evidence 
for sulfur ligation in any of the samples.  All orthologs studied appear to have similar but 
not identical metal binding characteristics using O/N based ligands. 
The x-ray absorption near edge (XANES) plot for WT Sc Isu1 is plotted with two 
octahedral iron model complexes, ferrous and ferric sulfate (Figure 2.4).  When 
compared to the models, pre-edge and edge features of the WT protein are similar to 
that of an octahedral oxygen/ nitrogen containing environment. Edge energy at half 
height of the rising edge for the WT sample is 7120 eV, and that for ferrous sulfate 
control is 7119.5 eV, indicating a ferrous iron-containing complex.  These results 
confirm the presence of an octahedral Fe (ll) complex bound to WT Sc Isu1.  
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Figure 2.4: XANES spectrum of Fe (ll) bound to WT Sc Isu1. Spectrum for WT Sc 
Isu1 shown in black solid line compared with two octahedral oxygen/nitrogen model 
complexes: Ferrous sulfate (-x-) and ferric sulfate (--).  Spectrum was collected at NSLS 
X3B in buffer containing 20 mM  HEPES (pH: 7.5), 250 mM NaBr, 5 mM β-Me. Two 
equivalents of Fe(ll) was added to protein. Samples were prepared after overnight 
incubation of protein & reagents in an anaerobic glove box. 
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2.5.3 Metal Site Electronic Structure by Mössbauer Spectroscopy 
 
Mössbauer spectroscopy was utilized as an alternative technique to probe the 
metal site electronic structure of ferrous iron bound to ISU proteins.  The 4.5 K 
Mössbauer spectra of each ISU protein anaerobically loaded with ferrous iron are 
shown in Figure 2.5 and each was consistent with high spin ferrous iron constrained 
within an octahedral ligand environment.  A single major quadrupole doublet was 
observed for all samples, with δ values of 1.24, 1.20, and 1.27 mm/s for Hs, Dm and 
Tm, respectively, and corresponding ΔEQ values of 2.35,1.94 and 2.76 mm/s (Table 
2.3). 
 
2.6 Discussion 
 The ISU family of proteins is essential for cellular Fe-S cluster assembly.  
This family is highly conserved in their amino acid sequence, indicating a common and 
ancient evolution.  In this report, we characterize the structural and electronic properties 
of ferrous iron bound to four members of the ISU family of proteins.  Although ISU has 
been shown at both a genetic and biochemical level to be the scaffold upon which Fe-S 
cluster biosynthesis is orchestrated [5, 7, 15], the mechanistic details of Fe-S cluster 
assembly still remain elusive and have been the subject of intense research efforts by 
many research groups.  Although cluster formation is chemically a simple task, it is still 
unclear how these events occur in a strictly controlled protein environment.  Both the 
sulfide and iron donors have been identified which promote transfer of these substrates 
to the scaffold protein however the subsequent cluster formation is difficult to observe  
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Figure 2.5.  Mössbauer spectra of ISU proteins.  Top to bottom: Human Isu 4.5K 
700G parallel field, Human Isu 100K 700G parallel field, Drosophila Isu 4.5K 400G 
parallel field, Thermatoga Isu 4.5K 400G applied field.  All samples have been collected 
~24h for about 3-4 M counts of radiation. 
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Table 2.3.  Analysis of Mössbauer parameters for Fe(ll) bound ISU proteins. 
Sample δ (mm/sec) ΔEQ (mm/sec) Lw (mm/sec) 
H.sapien 1.26 2.60 0.768 
D.melanogaster 1.24 2.83 0.801 
S.cerevesiae NA NA NA 
T.maritima 1.26 2.61 0.742 
Aq Fe (II) 1.35 3.06  
 
δ – Isomer shift  
ΔEQ – Electric quadrupole  
Lw – Line width at full width half maximum of signal 
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directly at a molecular level.   It has been shown structurally that the product of cluster 
formation is bound at the 3-Cys site and these 3 Cys residues are implicated as being 
active site residues [17].  ISU proteins have previously been shown to bind iron, but 
biophysical analysis of the metal center has always been after an intact cluster has 
been formed [15, 16].  To help further elucidate the mechanistic details of cluster 
formation by the ISU proteins, we characterized iron binding of ISU proteins across a 
variety of species.  A comparison of iron binding to ISU proteins by ITC shows these 
proteins are able to bind ferrous iron with low nanomolar and sub-micromolar affinities. 
These binding affinities are consistent with the copper chaperones have been studied to 
date [23].  
 Frataxin, the proposed iron donor within the Fe-S assembly pathway has been 
extensively studied using the human, fly, yeast and bacterial systems.  To date, all 
frataxin homologs studied have been observed to bind iron with binding affinities also in 
the low micromolar range [13, 24-26].  Binding affinities for iron by the ISU proteins that 
are tighter than the chaperones themselves suggests metal transfer is energetically 
favorable.  The process is most likely however much more complicated than simple 
inter-residue transfer, with multiple proteins and conformational changes ultimately 
leading to cluster formation.  The KD values reported by the Cowan group for Hs (KD= 
2.0 μM) and Tm (KD= 2.7μM) ISU proteins are lower than those reported here for Dm 
(KD1= 475 nM, KD2= 64.5 nM) and Sc (KD1= 234 nM, KD2= 6 nM), but this may be 
attributable to the fact that different solution conditions were tested during the 
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experiments.  It is clear that the different ISU proteins are capable of directly binding 
ferrous iron and this certainly has direct mechanistic implications regarding the protein’s 
enzymatic function.  We therefore probed the metal binding characteristic of these 
family members to further explore how clusters are assembled. 
 XAS and Mössbauer studies of ferrous iron bound to ISU proteins are consistent 
with a metal-ligand coordination environments constructed of only oxygen and nitrogen 
based ligands.  XANES analysis of the iron edge for each ISU ortholog is consistent 
with iron being stable in the ferrous state based on the first inflection point of the edge 
and the primary energy feature of the 1s→3d transitions.  In addition, the 1s→3d 
transitions areas and energies are consistent with the ferrous iron being stable in the 
high-spin state.  A quadrupole doublet observed in each Fe-ISU sample by Mössbauer 
spectroscopy, with δ values at ca. 1.25 mm/s and ΔEQ ~2 mm/s, also supports the 
presence of high spin ferrous iron.  Both Mössbauer and EXAFS analysis indicate the 
metal is coordinated to only O/N based ligands, these coordination environments differ 
slightly between species.  Best fit nearest neighbor environments for Hs ISU yield two 
O/N shells with coordination numbers of 1.5 and 4 at distances of 2.01 and 2.15 Å, 
respectively.  Long-range ligand interactions at distances of 3.13, 3.52 and 4.13 Å are 
most likely due to carbon atoms.  Dm Isu was also best-fit using two O/N ligand 
environment with 3 O/N atoms at 1.99 Å and 2 O/N atoms at 2.14 Å.  Long-range 
interactions were also best fit with a carbon shell at 3.13Å.  Similarly, Sc Isu1 was best 
fit with two shells, the first composed of 1 O/N at 2.01 Å and the second composed of 
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4.5 O/N at a distance of 2.14 Å.  The long-range interaction at 3.01 Å was best fit with 
carbon.  Iron bound Tm IscU show a slightly different coordination geometry with only a 
single O/N shell composed of 6 ligands at 2.13 Å, long-range carbon scattering was 
best fit at 3.27, 3.49 and 3.71 Å.   
 Simulations to the different Mössbauer data qualitatively support these XAS 
results.  The ISU proteins from different sources have somewhat different isomer shift 
and quadrupole splitting values, which suggests that the ligands are not precisely the 
same in each.  The isomer shift arises from differences in s-electron densities between 
source and absorber nuclei and is sensitive to oxidation and spin state.  Here we 
observe relatively high values (δ = 1.20-1.27) due to shielding of the outer s-electron 
charge density by the inner 3d electron charge density indicating a metal center in the 
S=2 high spin ferrous state.  Additionally this shielding leads to the high quadropole 
splittings of around 2-3 mm s-1.  Although line widths are not extraordinarily large it is 
possible they may indicate multiple spectral features, and therefore multiple species or 
binding sites.  Interestingly, the δ and ΔEQ for the different ISU proteins are not exactly 
the same.  This suggests some variation in coordinating ligands, with Tm having more 
oxygen and Dm having the most nitrogen with Hs and Sc in between.  
 In summary, these data report clear evidence that the ISU proteins have an iron 
binding site that is distinct from the Cys rich active site.  In particular, these data 
indicate: 1) ISU orthologs are able to bind iron with high affinity and 2) ferrous iron is 
bound initially via O/N based ligands.  In this report, we focused solely on the initial 
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process of iron binding to the ISU orthologs to gain insight into the Fe-S cluster 
assembly pathway.  It was originally assumed that both iron and sulfur addition to ISU 
scaffold proteins occurred at the 3 Cys active site.  Our data indicate ISU initially bind 
iron in a step prior to cluster assembly at a distinctly separate site composed entirely of 
non-cysteine ligands.  The techniques used in this study do not provide any information 
as to the identification of the residues that make up this initial metal binding site, nor 
how the metal is transferred from the iron binding site to the active site.  Insight into the 
conserved sequences may provide further clarification into how these proteins bind iron. 
Acidic residues are highly conserved in approximately 11 positions (9 of which are 
completely conserved in our alignment) and 3 partially conserved His residues.  We 
therefore plan to target each of these residues in the future to provide better clarification 
into which are at the Fe binding site. 
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CHAPTER 3 
IDENTIFICATION OF A PUTATIVE IRON BINDING SITE ON THE C-TERMINUS OF 
YEAST IRON-SULFUR SCAFFOLD PROTEIN ISU & 
IMPLICATIONS FOR IRON DELIVERY BY FRATAXIN 
 
 
3.1 Prelude 
This chapter describes my work directed at the identification and characterization 
of the ISU Fe binding site described in Chapter 2.  X-ray absorption spectroscopy (XAS) 
studies showed that this site was found to be composed entirely of oxygen/nitrogen 
based ligands, distinct from the protein’s thiol rich active site.  The goal of this work is 
therefore, to identify the region & and residues on ISU, in the yeast model (YIsu1), that 
constitute this initial Fe binding site.  Site directed mutagenesis and subsequent 
spectroscopic, calorimetric and kinetic analysis of the mutant proteins in comparison to 
the wild-type (WT) and in the presence/absence of Frataxin were employed in this study.  
These results aim to provide insight, at the atomic level, into the delivery of iron to YIsu1 
and, subsequent loading of its cysteine rich active site.  Contributors to this work were 
Dr. Ashoka Kandegedara, a postdoctoral researcher in the Stemmler lab who designed 
and performed a competition assay to determine Fe(ll) binding affinities of wild type 
(WT) YIsu1 and mutants, graduate student Stephen Dzul, who aided in development of 
a time-dependent Circular Dichroism assay to determine activity of Fe-S synthesis of 
YIsu1 proteins, and a summer undergraduate student (2011-13), John Rotondo who 
aided in protein purification and collection of Far UV CD experiments.  This work is 
being prepared for submission to the journal Biochemistry. 
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3.2 Abstract 
Eukaryotes utilize the protein ISU as a scaffold for the assembly of iron-sulfur 
clusters within the mitochondria.  Yeast Isu1 (YIsu1) contains three conserved cysteine 
residues at its active site that coordinate the utilization of ferrous iron, Fe(II) and 
inorganic sulfide, S2- for assembly into a 2Fe-2S cluster.  We have previously shown 
that YIsu1 binds two iron atoms with sub-micromolar to nanomolar affinity and that 
YIsu1 interacts with the yeast Frataxin homologue 1 protein (Yfh1) in an iron-dependent 
manner.  Frataxin has since been described to participate in cluster assembly as an iron 
donor and a pathway modulator.  Although its function is essential, atomic details of its 
interactions with partner proteins are still lacking.  Recently, we have found by X-ray 
absorption spectroscopy (XAS) and Mössbauer spectroscopy (manuscript in 
preparation) that YIsu1 binds iron in a 6 coordinate octahedral oxygen/nitrogen (O/N) 
based ligand environment free of thiol ligation, indicating that YIsu1 binds Fe initially at a 
site independent of the protein’s cysteine rich active site.  In this report, we demonstrate 
that the C-terminal residues of YIsu1 participate in iron loading leading to a possible 
molecular rearrangement that drives a structural switch to enable iron translocation to 
the thiol rich protein active site in order to accomplish Fe-S cluster assembly.  Iron 
binding competition assays and isothermal titration calorimetry experiments show a 
reduction in the Fe(II) and Frataxin binding affinity for mutant YIsu1 forms (E144A and 
D145A). Differential scanning calorimetry studies, comparing holo-WT YIsu1 to mutants, 
show a change in stability and associated thermodynamic parameters.  Finally, our in 
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vitro Fe-S assembly assay shows mutant YIsu1 has a dramatically perturbed ability to 
complete Fe-S cluster biosynthesis, as compared to the WT protein.  Based on these 
results, we speculate that the residues E144 and D145 on the YIsu1 C-terminal α-helix 
serves as a possible initial iron-binding site on the scaffold protein, and that metal 
delivered to this site can then be utilized for Fe-S cluster assembly. 
 
3.3 Introduction 
Iron sulfur (Fe-S) clusters are indispensible for life [1]. These inorganic cofactors 
have a high degree of chemical versatility which allows them to participate, when bound 
to proteins, in several reactions that include electron transfer (complex 1 & 2 of the 
electron transport chain) [2], enzyme catalysis (mitochondrial Aconitase that functions in 
glycolysis) [3], signal transduction (DinG that participates in DNA repair) [4] and sensing 
of cellular metabolites such as oxygen and Fe content (Cytosolic Aconitase/IRP) [5, 6].  
As these pathways are essential to sustain life, an inability to synthesize these clusters 
is a condition that is incompatible to life [7].  
The assembly of iron sulfur clusters occurs by a highly regulated protein 
controlled process owing to the instability of the cofactor in aerobic environments and 
the inherent toxicity of free iron and sulfide [8-10].  The formation of a multiprotein 
complex ensures efficient production and delivery of clusters, while at the same time 
actively suppresses free radical formation by free iron and the cyanide-like effects of 
free sulfide [11].  In yeast, this complex is found within the mitochondria and is 
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composed of the cluster assembly scaffold protein (Isu1), the cysteine desulfurase that 
provides sulfur for cluster assembly (Nfs1), the Nfs1 accessory protein (Isd11), a 
ferredoxin that provides reducing equivalents for cluster assembly (Yah1) and the 
protein frataxin (Yfh1), which has been suggested to serve as an iron chaperone that 
delivers Fe(II) for cluster assembly, a regulator of Nfs1 activity [12].  Defects or 
deficiencies in these proteins have been associated with several human diseases [7, 
13].  A deficiency of Frataxin causes the debilitating disease Friedreich’s Ataxia (FRDA), 
associated with pooling of iron in the mitochondria of nerve and muscle tissues of 
affected individuals leading to progressive neurodegeneration and cell death [14, 15].  In 
addition to disrupted iron homeostasis, cardiac biopsies of FRDA patients exhibited 
decreased activity of several Fe-S containing proteins, such as Aconitase, and proteins 
of the electron transport chain involved in respiration, such as Complexes I, II & III [13, 
16].  A genetic deficiency of ISU, caused by a splice-defect, has been reported to be 
associated with muscular dystrophy in humans, due to a deficiency of Fe-S containing 
proteins Succinate dehydrogenase and Aconitase [17, 18].  In yeast, Isu1 and 2 are 
YIsu paralogs that show a combined deletion mutant lethality [19].  
The active site of all Isu orthologs contains conserved cysteine residues that 
coordinate the assembled iron-sulfur cluster [20].  Our XAS studies have shown that 
YIsu1 binds iron at a site comprising a 6 coordinate O/N ligand environment [8].  In 
addition, our XAS and Mössbauer studies on Fe(ll) bound to ISU proteins in the human, 
fly and T. maritima orthologs show the same trend (chapter 2).  This suggests ISU must 
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bind iron at an initial acceptor site that is distinct from its Cysteine rich active site.  The 
occurrence of a distinction between a metal acceptance site from a substrate binding 
site has been described previously for iron delivery to the protein Ferrochelatase that 
participates in heme biosynthesis [21]. 
The crystal structure of IscU from Aquiflex aeolicus has shown distinct structural 
differences in the IscU C-terminus dependent on the presence and absence of bound 
cluster [20].  There appears to be an increase in order of the N-terminal region of the 
IscU C-terminal helix coupled to cluster formation.  Our previous studies have shown 
that YIsu1 undergoes changes in fold upon substrate binding.  Using the ANS 
chromophore, we have shown that binding of both Fe(ll) and S2- to Isu1 is associated 
with an increase in order of the protein’s fold [8].  Recently, solution structural studies by 
the Markley lab have shown that Isu does indeed exist in equilibrium between two 
structural conformations: a "structured” (S) and “disordered” (D) states [22].  The D state 
has been reported to be the substrate for Nfs binding.  Cluster synthesis then drives the 
protein to the S state, which is the substrate for co-chaperone proteins that remove the 
cluster and drive the downstream delivery of cofactor to target apoproteins [23]. 
In this report, we study the properties of charged and conserved amino acid 
residues on the YIsu1 C-terminus (residues E144 and D145) with regards to iron 
binding, their interaction with Frataxin and Fe-S assembly.  Using site directed 
mutagenesis, these residues were mutated to alanine.  Using competition-binding 
studies, mutated proteins show a decrease in Fe(ll) binding affinity by up to 8 fold, in 
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case of the E144A mutant, and up to 5 fold, in case of the D145A mutant.  In addition, 
interactions between these mutant proteins and holo-Frataxin, measured using 
isothermal titration calorimetry (ITC), showed pronounced changes in binding 
energetics.  Differential scanning calorimetry (DSC) was used to test the stability of the 
apo and holo forms of both WT and mutant protein.  Finally circular dichroism (CD) 
spectroscopy was used to test the overall fold of the mutants and to test the ability of 
these mutants to synthesize Fe-S clusters.  For Fe-S assembly, although WT YIsu1 
showed an increased activity upon Frataxin binding, the D145A mutant protein behaved 
differently in the presence of Frataxin, possibly due to changes in associated energetics 
permitting assembly by an alternative mechanism.  The involvement of these residues in 
initial iron loading of YIsu1 is explored in detail below. 
 
3.4 Materials & Methods 
3.4.1 Site Directed Mutagenesis & Protein Expression:   
Characteristics of expression and isolation of wild type YIsu1 have been outlined 
within Chapter 2.  The Quickchange site directed mutagenesis kit (Stratagene) was 
used to make point mutations (E144A, D145A, and double mutant E144A, D145A) on 
the pET21b plasmid containing the YIsu1 gene without the N-terminal targeting 
sequence (Δ1-32 YIsu1).  Forward and reverse primers were designed using 
Quickchange primer design program and were purchased from Invitrogen (Table 3.1).  
Mutations were confirmed by DNA sequencing (Genewiz).  Plasmids containing the 
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YIsu1 wild type (WT YIsu1) and mutant genes were transformed into BL21 codon plus 
RIL cells (Stratagene) for protein expression.  Cells were grown at 370C in Luria-Bertani 
broth containing Ampicillin (0.1 μg/μl) and Chloramphenicol (0.05 μg/μl) with shaking 
speed set at 250 rpm.  At OD600 of 0.6, cells were induced for protein expression by the 
addition of 0.8 mM IPTG.  Post induction expression conditions were found to be 
optimum at a temperature of 37 0C, over a period of 3 hrs. following which the cells were 
harvested by centrifugation and stored at -80 0C until lysis.  
 
3.4.2 Protein Purification:   
All protein isolation steps were carried out at 40C.  Cells were re-suspended in 
buffer containing 50 mM NaPO4 (pH 7.4), 300 mM NaCl, 10 mM Imidazole, 5 mM β-Me 
(5 ml buffer/g cells) in the presence of lysozyme (100 μg/μl), a complete EDTA free 
protease inhibitor tablet (1 tablet/ 50 ml, Roche), DNAse (10 μg/ml) and MgCl2 (5 mM), 
and then allowed to incubate for ~15 mins.  Cells were lysed by three passes through a 
high-pressure homogenizer (Emulsiflex C3, Avestin) and centrifuged at 21,000 rpm for 
one hour.  The supernatant was separated and filtered using a 0.2 μm filter and the 
crude soluble fraction was loaded onto a bench top column filled with Ni-NTA (Qiagen) 
affinity resin.  Using a stepwise imidazole gradient (20-500 mM), YIsu1 eluted at a 
concentration of ~200 mM Imidazole.  Fractions containing protein were pooled and 
treated with 5 mM EDTA (overnight), followed by concentration to 1 ml using 10 KDa 
cutoff Amicon filters and then loaded onto a Sephadex 75 gel filtration column (GE) 
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Figure 3.1:  Amino acid sequence comparison of the C-terminal region of Isu1 
orthologs.  Human (HsISU), Mouse (MmISU), Zebrafish (DrIsu), Bacteria (AvIscU) and 
yeast (ScIsu1).  Conserved residues in the proposed Fe binding site are in green and 
pink while the c-terminal most conserved cysteine residues at the Isu active site is in 
yellow. 
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           Table 3.1: List of primers used for Site Directed Mutagenesis 
 
 
Primer Name   Primer Sequencea 
YIsu1 E144A forward   5'-GCTCTATGTTAGCGGCAGATGCGATCAAGGC-3' 
YIsu1 E144A reverse 
 
5'-GCCTTGATCGCATCTGCCGCTAACATAGAGC-3' 
   
YIsu1 D145A forward 
 
5'-GCTCTATGTTAGCGGAAGCGGCGATCAAGGCAGC-3' 
YIsu1 D145A reverse 
 
5'-GCTGCCTTGATCGCCGCTTCCGCTAACATAGAGC-3' 
   YIsu1 E144A, D145A 
forward 
 
5'-GCTCTATGTTAGCGGCAGCGGCGATCAAGG-3' 
YIsu1 E144A, D145A 
reverse 
 
5'-CCTTGATCGCCGCTGCCGCTAACATAGAGC-3' 
 
    
a Mutated residues are represented in italics and underlined. 
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equilibrated with 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me.  The protein 
eluted at a volume corresponding to a dimer, pure fractions were pooled and protein 
concentration was determined using IR Spectrometry (EMD Millipore Direct Detect).  
Purification yielded about 2mg/ml of ≥95% pure protein from ~50 gm cells.  Molecular 
weights for WT YIsu1 and mutant proteins were confirmed by Mass Spectrometry 
(Table 3.2). 
 
3.4.3 Far UV Circular Dichroism:   
Pure protein samples of 250-300 μl volume were dialyzed using 3.5 KDa cutoff 
dialysis membranes (Spectrum Labs) into 1 mM NaPO4 (pH 7.5) buffer of 300 ml 
volume for 3 hrs at 40C with 1 buffer change in between.  Spectra were collected at a 
concentration of both 10 uM and 25 uM using JASCO J-1500 CD spectrometer with a 1 
mm pathlength cuvette over a range of 185-260 nm with a scanning speed of 50 
nm/minute at room temperature.  Prior to data collection, the instrument was baselined 
without a cuvette to eliminate any background spectral contributions from the 
instrument.  Presented data represent an average of two independent preparations for 
each protein sample, and each dataset is an average of 8-12 scans.  Data were 
analyzed using the Spectra Analysis software provided by JASCO.  Baseline correction 
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Table 3.2: Masses of YIsu1 WT and mutants 
Sample Calculated Mass  (Da) 
Experimental Mass  
(Da) 
WT 15515.9 15514.4a 
D145A 15471.8 15471a 
E144A 15457.8 15456.2a 
E144A D145A 15413.8 15407b 
a Determined by ESI-MS 
b Determined by Average Mass Spectrometry 
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was accomplished by subtracting an averaged buffer spectrum from each averaged 
protein spectrum.  Data were fit using the CD Pro fitting program provided by JASCO. 
Reference databases for soluble proteins namely SP29, 37 and 43 were used and best 
fits were obtained using the CONTIN method.  Fits with the lowest RMSD values were 
selected and averaged.  CD curves were smoothed for display and secondary structure 
percentages were tabulated from raw unsmoothed data.  Standard deviations between 
averaged runs are denoted in parenthesis 
. 
3.4.4 Isothermal Titration Calorimetry experiments & analysis:   
 
The binding properties of YIsu1 WT and mutant proteins to Fe(ll) and to holo 
Yfh1WT were tested using ITC.  Protein and aqueous ferrous ammonium sulfate 
solutions were prepared anaerobically in a glove box (Coy Laboratories) in buffer 
containing 20 mM HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me.  Protein samples 
were maintained at 40C and buffers were extensively degassed prior to sample 
preparation and loading.  Holo Yfh1 was prepared by incubating equimolar amounts of 
Yfh1WT and Ferrous Ammonium Sulfate solution 15-30 minutes prior to use.  ITC data 
were collected on a TA Instruments Nano ITC calorimeter located within the Coy 
anaerobic chamber by titrating 1 mM holo Yfh1 WT into a 1.3 ml volume of 50 uM 
protein solution.  Data collection parameters followed a 2 μl initial injection of titrant 
solution followed by 35 additional injections of 7 μl using a 250 μl syringe.  Injections 
were spaced at 10 minutes each and data was collected at 300C with stirring speed set 
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at 250 rpm.  Control experiments of 1 mM holo Yfh1WT titrated into buffer was 
subtracted from the experimental data to eliminate background heats of dilution.  Data 
analysis was performed utilizing the Nano Analyze software provided by TA instruments 
using a multiple sites model for curve fitting and analysis.  All experiments were 
performed in duplicate on independent samples to ensure data reproducibility. 
3.4.5 Competition Assay:   
The affinity of WT YIsu1 and mutants proteins for Fe(II) was determined by 
competition titrations using Mag-fura-2 (Molecular Probes), a well-known metal chelator 
that binds ferrous iron.  Mag-fura-2 forms a 1:1 complex with most divalent cations and 
has an absorbance maximum at 366 nm that shifts to 325 nm when metal is bound.  
The decrease in absorbance at 366 nm as Mag-fura-2 binds increasing amounts of Fe 
(II) in competition with the protein was monitored on a Shimadzu UV-1800 
spectrophotometer using 1 cm pathlength quartz cuvettes.  Data were collected at room 
temperature within an anaerobic chamber (Coy Laboratories).  Mag-fura-2 was 
dissolved in high purity MiliQ water and stored at -80⁰C in 10 μL aliquots of 2 mM stock 
concentration.  Protein samples and ferrous ammonium sulfate solutions were prepared 
in buffer containing 20 mM HEPES (pH 7.5) and 150 mM NaCl.  Prior to use, protein 
samples were reduced with 5 mM TCEP.  All protein samples, reagents and buffers 
were allowed to incubate at 40C overnight in an anaerobic chamber before data 
collection.  For the control reaction, the initial starting solution contained 2-5 µM Mag-
fura-2 in 1 ml of reaction buffer, aliquots of Fe (II) of varying volumes were then titrated 
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until saturation.  Each spectrum was collected from 200-800 nm for each ‘i’th addition of 
metal aliquot.  Dilution correction was performed by carrying out the same experiment 
using buffer instead of Fe(II).  For protein titrations, the same procedure was followed 
except that 10-20 µM of protein was mixed with Mag-fura-2 at the beginning of the 
binding reaction.  Metal free Mag-fura-2 concentrations was confirmed using the 
molecules’ molar absorptivity (ε) value at 366 nm that is 29900 M-1cm-1 [24].  The 
dissociation constant of Fe (II)-Mag-fura-2 complex under the above buffer conditions 
was determined to be 2 (±0.07) μM.  Data were fit using the program DYNAFIT [25] with 
both one and two-site binding models. Our reported Kd values are an average 3 runs.  
 
3.4.6 Differential Scanning Calorimetry experiments & analysis:   
Thermal stability of the WT- and mutant YIsu1 samples in the absence and 
presence of iron were evaluated using a VP Differential scanning calorimeter (TA 
Instruments) to determine stability parameters associated with the mutants in the apo 
and holo forms.  Protein and iron solutions were prepared anaerobically in 20 mM 
HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me.  Buffer was extensively degassed prior 
to sample preparation and loading.  Protein concentrations of 1.25 -1.5 mg/ml were 
used and iron solution was added to obtain samples upto a 1:2 protein:Fe ratio and 
made up to a final volume of 600 μl.  YIsu1 WT remained stable upon addition of Fe, 
however slight precipitation was observed among the mutants, which was removed by 
centrifugation, and the change in protein concentration was noted.  Scans were run at a 
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rate of 20C per min over a temperature range of 10-900C, while pressure was 
maintained at an excess of 2.95 atm throughout the scan period.  Data obtained were 
analyzed using the Nano Analyze software provided by TA Instruments.  Data was 
baseline subtracted using control runs of buffer alone or buffer with iron at 
concentrations that matched the amount in protein samples.  Peak deconvolution was 
achieved using the two state scaled mathematical model that incorporates the Aw factor, 
which accounts for inaccuracies in protein concentration upon denaturation.  Data 
presented represents an average of two independent samples.  
 
3.4.7 Near UV CD for Assembly Activity:  
The cluster reconstitution of apo WT YIsu1 and mutants was tested by time 
course CD spectroscopy.  All proteins, reagents and the buffer solution of 20 mM 
HEPES (pH 7.5), 150 mM NaCl and 5 mM β-Me, were allowed to incubate overnight in 
an anaerobic chamber.  Protein and buffer were maintained at a temperature of 40C 
overnight.  All solutions were prepared in the above-mentioned buffer within the 
anaerobic chamber immediately prior to data collection.  The reaction mixture consisted 
of 100 uM apo YIsu1 WT or mutant, 200 uM ferrous ammonium sulfate solution or 200 
uM holo Yfh1 (prepared by incubating equimolar concentrations of Yfh1 and Fe(ll) for 
15-30 minutes prior to use) and 1 M Na2S solution made up to a final volume of 1.2 ml.  
Data was collected on a JASCO J-1500 CD spectrometer at room temperature with a 1 
cm pathlength cuvette, which was capped to eliminate any air induction.  The instrument 
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was baseline subtracted without a cuvette prior to data collection to eliminate any 
background spectral contributions from the instrument.  Data was recorded over 300-
700 nm and 2 scans were collected at a scanning speed of 100 nm/min; these scans 
were then averaged.  The mixture was subjected to agitation using a magnetic stir bar 
for 30 seconds prior to data collection.  Scan sets were collected every 10 minutes until 
signal saturation was observed.  Data were averaged using the Spectra Analysis 
software provided by JASCO.  The absorbance signal at 435 nm was used for activity 
plots of absorbance v/s time, plotted using Kaleidagraph.  
 
3.5  Results 
3.5.1 Mutant proteins have a similar fold as wild-type (WT) YIsu1:  
Far UV CD spectroscopy was used to compare the relative protein fold of WT 
and mutant Isu1 proteins.  WT and mutant YIsu1 proteins were all well folded with a 
similar secondary structural content.  Far UV CD results showed the presence of two 
predominant secondary structural features: α-helix (positive feature at 192 nm and 
negative at 208 nm & 222 nm) and β-sheet (negative feature at 218 nm and positive at 
196 nm) [26] in WT YIsu1 and to a similar degree in the mutant spectra (Figure 3.2).  
The wild type protein shows a secondary structural makeup of 20 (± 7)% α-helix, 26 (± 
7)% β-sheet, 22 (± 1)% turns and 32 (± 1)% unordered (Table 3.3) with an RMSD  
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Figure 3.2:  Far UV Circular Dichroism spectra of apo YIsu1 WT and mutants.  
Data were collected at room temperature over a wavelength range of 190-260 nm in 
1mM NaPO4 (pH 7.5).  The panels below represent: (A) WT (B) E144A (C) D145A (D) 
E144A, D145A YIsu1 spectra. 
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Table 3.3: Secondary structural features from simulation of CD spectra for YIsu1 
WT and mutant proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secondary 
Structurea 
% Fold with standard deviation 
 
WT 
 
E144A 
 
D145A 
 
E144A, D145A 
Helix 
 
20(±7) 
 
26(±2) 
 
22 
 
21(±4) 
Sheets 
 
26(±7) 
 
20(±2) 
 
23 
 
26(±3) 
Turns 
 
22(±1) 
 
23(±1) 
 
23 
 
22 
Unordered 
 
32(±1) 
 
31(±1) 
 
32 
 
31(±1) 
TOTAL 
 
100 
 
100 
 
100 
 
100 
RMSDb 
 
0.07 
 
0.07 
 
0.07 
 
0.05 
a Circular Dichroism data collected in 1mM NaPO4 (pH 7.5) from 190-260nm 
b % error between experimental and calculated values 
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between data and simulation of 0.07 ± 0.007 corresponding to an error of ca. 7% which 
is the difference between the calculated and experimentally determined CD spectrum.  
Minor differences in simulation parameters observed between WT and mutant proteins 
include a reduction of up to 6% in β-sheet content for the E144A protein and 3% for the 
D145A protein with a corresponding increase in α-helical content suggesting a slight 
change in fold for the mutants.  Secondary structural simulations for the double mutant 
are almost identical to the WT protein. 
YIsu1 WT showed the highest standard deviation of approximately 7% between 
averaged runs for α-helix and β-sheet secondary structures, while the D145A mutant 
showed no change in secondary structure between averaged runs. 
 
3.5.2 YIsu1 mutants show a decreased Fe(ll) binding affinity: 
As the environment within a cell contains several potential metal ligands, using 
chelators that compete with the protein of interest for metal binding has been reported to 
be a more relevant method of obtaining a more physiological binding constant for 
protein-metal binding [27].  In this report, we have used the chelator Mag-fura-2 as a 
competitor for Fe(ll) binding with WT YIsu1 and mutant proteins.  The metal-free 
chelator has an absorbance maximum at 366 nm, which decreases upon increasing Fe 
(ll) binding, and this is monitored by UV-Visible spectroscopy [24] (Figure 3.3, inset).  
Data obtained were fit using the program DYNAFIT [25].  Initial titrations of Fe(ll) to 
Mag-fura-2 were best fit to a one-sites model with a KD of 2.00 (±0.07) μM under these 
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experimental conditions.  Isu proteins have reported KD values in the nanomolar to 
micromolar range [8, 28], therefore a competition between the two ligands for Fe(ll) can 
be envisioned. Using this assay, WT YIsu1 was best fit with a two-sites model with 
binding affinities in the micromolar range at both sites of KD1 2.38 (±0.85) μM and a KD2 
of 4.55 (± 2.69) μM.  The one-sites fit had large estimated errors (Table 3.4).  
Previously reported values using isothermal titration calorimetry (ITC) indicate binding 
affinities for YIsu1 in the nanomolar to micromolar range [8].  However using Trp 
fluorescence, micromolar binding affinities for Tm IscU were reported using a two-site 
model for fitting [28].  As ITC measures total heat, we speculate the possibility of 
contributions due to conformational changes in the protein upon substrate binding.  The 
mutant protein E144A was best fit with a two-sites model and showed a slight rise in KD1 
of 4.95 (± 0.91) and an eight-fold rise in KD2 of 38.1 (± 22) compared to the WT protein.  
Again the one-sites fit had high estimated errors.  The D145A mutant showed a similar 
trend with a slight rise in KD1 of 7.60 (± 2.60) and six-fold rise in KD2 of 26.2 (± 12.1) 
compared to WT.  This mutant however, yielded an acceptable fit with a one-sites 
model.  Finally, the E144A, D145A mutant was best fit with a one-sites model with a KD 
of 3.15 (± 1.43).  Fits with a two-sites model yielded high errors.  As the single mutant 
proteins were associated with a significant drop in binding affinities associated with one 
of the sites, with the other site being largely unaffected, these results suggest the 
possible loss of one Fe(ll) binding site. 
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Figure 3.3: Competition Assay between Mag-fura-2 and YIsu1 proteins with 
Fe(II).  (A) Data was fit with DYNAFIT.  Curves correspond to WT YIsu1 13 µM 
and 5.5 µM Mag-fura-2; D145A 10.3 µM and 9.4 µM Mag-fura-2; E144A 5.4 µM 
and 3.9 µM Mag-fura-2; E144A, D145A 8.0 µM and 3.3 µM Mag-fura-2. Fe(ll) was 
titrated in increasing concentrations. (B) Inset: Initial absorbance spectra 
obtained during titration of 5 µM of Mag-fura-2 and 15 µM WT YIsu1 Fe (II) in 20 
mM HEPES (pH 7.5), 150 mM NaCl, at 25⁰C.  The arrows denote the direction of 
the absorbance changes with increasing concentrations of Fe(II). 
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Table 3.4:  KD values obtained from Mag-fura-2 assay for WT YIsu1 and mutant 
proteins.  Data was fit to two binding site model using DYNAFIT and average values of 
(n=3).  KD1 and KD2 are given with errors for YIsu1 monomer in 20 mM HEPES (pH 7.5) 
150mM NaCl and 5 mM TCEP, at 25 ⁰C. 
         a Error associated with fit were very high. 
 
 
 
 
 
 
 
 
 
 
 
 
  
	  
YIsu1 Protein KD1 (µM) KD2 (µM) KD One -sites 
WT 2.38 ± 0.85 4.55 ± 2.69 -a 
E144A 4.95 ±  0.91 38.1 ± 22.0 12.0 ± 14.0 
D145A 7.60 ± 2.60 26.2 ± 12.1 3.96 ± 0.77 
E144A,D145A 2.99 ± 0.11 -a 3.15 ± 1.43 
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3.5.3 Thermal Stability of YIsu1 proteins by Differential Scanning Calorimetry 
(DSC): 
The changes observed above in number and affinity of ligand and protein partner 
binding characteristics of YIsu1 mutants in comparison to WT possibly arise due to 
changes in energetics at the binding interface with Fe(ll) and/ or due to global changes 
in the stability & dynamics of the C-terminal helix.  DSC is a sensitive technique that can 
be used to study the changes in protein stability and associated energetics upon residue 
mutation and was applied to study YIsu1 WT and mutants in the absence (Apo) and 
presence (Holo) of Fe(ll).  ‘Holo’ protein refers to protein pre-loaded with two equivalents 
of Fe(ll) to maintain consistency with YIsu1’s maximal Fe(ll) binding ability.  All 
experiments were performed anaerobically in duplicate with independent protein 
preparations.  Data were fit using the two-state scaled model.  The approximation of 
enthalpy values i.e., ΔHcal (kJ/mol), obtained upon peak integration, to the Van’t Hoff 
enthalpy ΔHvH (kJ/mol), obtained upon model fitting is used an indicator of validity of 
the model to the system that it is applied to i.e.  
  ΔHcal = ΔHvH or  
 ΔHcal /ΔHvH = 1.  [29] 
Apo WT alone, and mutant proteins both; in the apo and holo form were best fit with two 
two-state transitions possibly corresponding to an equilibrium between structured and 
disordered states as previously reported for Isu proteins [22].  The apo proteins showed 
varying percentages of the two states (grey fits, Figure 3.4).  Holo WT alone was best 
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fit with a single transition indicating almost a 100% switch in protein structure upon Fe(ll) 
binding.  For Apo WT, temperature maximum for the first transition was 47.34 ± 0.380C 
and the second transition was 51.36 ± 0.260C.  Holo WT melted at a higher temperature 
of 54.65 ± 0.060C indicating a significant increase in stability upon Fe(ll) binding with an 
associated shift in structure that does not significantly disrupt the associated enthalpy or 
entropy compared to apo WT (Table 3.4).  The E144A mutant showed a slight increase 
in stability of both the apo and holo forms compared to WT.  This mutant has previously 
been reported to stabilize the Isu fold in the structured state in E.coli [22].  In the apo 
form, temperature maximum for the first transition was 51.00 ± 1.200C and second 
transition was 53.60 ± 0.900C, an approximate 3 degree shift toward stability compared 
to WT. The holo form was more stable, but was fit with a two-state transition, unlike holo 
WT and appeared to be in equilibrium between two states: a smaller percentage that 
melted at temperatures similar to holo WT i.e., 54.65 ± 0.060C while majority of the 
protein was associated with an even more stable state that melted at 61.07 ± 0.280C.  
Holo E144A was also associated with a four-fold rise in enthalpy and entropy compared 
to the apo form indicating Fe(ll) binding was an enthalpically unfavorable, yet 
entropically favorable reaction.  Apo D145A exhibited a melting temperature that was 
similar to apo WT however, the holo form on the other hand was associated with a 
decrease in stability. The temperature maximum for holo D145A upon Fe(ll) binding 
dropped to 42.68 ± 0.370C for the first transition and 49.50 ± 0.160C for the second 
transition.  Enthalpy and entropy showed a three-fold increase in the holo form  
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Figure 3.4: Thermal denaturation curves for apo and holo YIsu1 proteins.  Data 
collected using a Nano DSC instrument over 10-900C at a scan rate of 2 0C/ min in 20 
mM HEPES (pH:7.5) 150 mM NaCl & 5 mM β-Me at excess pressure of 2.95 atm for 
WT YIsu1 (A) and mutants E144A(B), D145A(C) and double mutant E144A, D145A(D). 
‘Holo’ refers to protein pre-loaded with 2 equivalents Fe(ll), Apo protein curves are offset 
for clarity. Black solid lines represent the fit to raw data, black dashed lines represent 
raw data, and grey solid and dashed lines represent deconvolution of raw data using the 
two-state scaled model. 
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YIsu1 variant State Tmfit1 Tmfit2 TMax ΔHvH ΔHcal ΔHcal/ ΔScal 
(0C) (0C) (0C) (kJ/mol) (kJ/mol) ΔHvH (kJ/mol.K) 
A) WT Apo 47.34 ± 0.38 51.36 ± 0.26 51.26 8.40 7.94 0.95 0.025 
Holo - 54.65 ± 0.06 55.29 5.76 5.10 0.90 0.016 
B) E144A Apo 51.00 ± 1.20 53.60 ± 0.90 51.92 4.48 3.97 0.89 0.012 
Holo 54.63 ± 0.58 61.07 ± 0.28 60.82 18.85 18.40 0.98 0.055 
C) D145A Apo 48.38 ± 0.50 51.79 ± 0.15 50.86 25.76 25.98 1.01 0.080 
Holo 42.68 ± 0.37 49.50 ± 0.16 48.76 66.33 63.63 0.96 0.200 
D) E144A, 
D145A 
Apo 43.92 ± 0.43 47.85 ± 0.80 45.32 9.23 8.29 0.90 0.026 
Holo 51.26 ± 0.30 61.72 ± 0.18 61.46 21.35 20.76 0.97 0.018 
Table 3.5: Thermodynamic parameters of melting of WT YIsu1 and mutant proteins.  Tmfit1 & 2 and 
represent temperature maximum for each transition fit to raw data.  ΔHvH represents Van't Hoff enthalpy 
which is total enthalpy under each fit obtained upon correction with scaling factor Aw. ΔHcal, ΔScal and 
Tmax represent enthalpy, entropy and maximum temperature obtained from peak integration after 
baseline correction of raw data.  Values for ΔHvH, ΔHcal and ΔScal show a similar trend between 
datasets.  
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compared to apo D145A.  Both apo and holo D145A proteins were fit with two two-state 
models with no apparent variation in the percentages of each state.  The double mutant 
E144A, D145A showed a decreased stability in the apo form.  Temperature maximum 
for the first transition was 43.92 ± 0.430C and the second transition was 47.85 ± 0.800C.  
Fe(ll) binding showed a melting pattern with an increased stability and was fit with two 
two-state transitions in a manner similar to that of holo E144A.  The holo form, just like 
the single mutants was associated with an three fold increase in enthalpy compared to 
its apo form, however, the associated entropy appeared to be similar to that of WT. The 
rise in molar heat capacity in Figure 3.4 upon Fe(ll) binding in the mutant proteins can 
be attributed to thermodynamic changes in enthalpy and entropy. 
 
3.5.4: YIsu1 mutant proteins show altered holo-Yfh1 WT binding: 
ITC was performed to study the binding affinity, binding ratio and thermodynamic 
parameters associated with the interaction between holo-yeast frataxin (Yfh1WT) with 
WT YIsu1 and mutant proteins (Figure 3.5).  Our previous studies have shown that 
Yfh1WT and WT YIsu1 do not interact in the absence of Fe(ll), therefore all experiments 
described below were performed using holo Yfh1WT prepared as described above in 
the materials & methods section [8].  All data was collected anaerobically on a TA Nano-
ITC instrument and in duplicate on independent protein samples to ensure 
reproducibility.  Prior to fitting and analysis, a control experiment of 1 mM holo-Yfh1WT 
titrated into buffer was subtracted from the raw data.  The binding of holo-Yfh1WT to 
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Figure 3.5: Holo-Yfh1 to YIsu1 protein titrations: Raw ITC data (top) and binding 
isotherm data after control subtraction (bottom) of holo yeast frataxin (Yfh1WT) binding 
to (A) YIsu1 WT (B) YIsu1 D145A (C) YIsu1 E144A, D145A.  The black solid line in the 
binding isotherm panel represents the simulated fit to the data after control subtraction. 	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Sample N1 KD1 (nm) N2 KD2 (μM) 
dH1 
(KJ/mol) 
dH2 
(KJ/mol) 
dS1  
(J/mol-K) 
dS2  
(J/mol-K) 
WT -- Fe-Yfh1 0.20 ± 0.07 2.94 ± 1.79 2.13 ± 0.94 0.11 ± 0.06 -1.61 ± 0.46 -0.52 ± 0.50 144 ± 21.51 81 ± 78.17 
D145A -- Fe-Yfh1 0.20 ± 0.01 95.2 ± 77.9 0.85 ± 0.07 2.91 ± 2.54 1.01 ± 0.13 1.63 ± 0.67 139 ± 6.93 113 ± 6.36 
E144A, D145A -- FeYfh1 0.34 ± 0.02 51.5 ± 15.4 0.68 ± 0.01 0.86 ± 0.02 2.45 ± 0.07 1.26 ± 0.18 148 ± 2.83 120 ± 0.85 
aAveraged values of stoichiometry v/s the Isu1 monomer.   
N1, N2, dissociation constants KD1, KD2, enthalpy dH1, dH2 and entropy values dS1, dS2  are given with errors. 
Table 3.6: Average Simulation Results using ITC Analysisa for WT YIsu1 and mutant proteins 
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WT YIsu1 follows an exothermic pattern with an initial exponential binding curve 
followed by a constant heat release pattern consistent with sample dilution in the post 
saturation stage.  Data was best fit using the multiple sites model with a total of two 
binding molecules at two binding affinities of 2.94 (±1.79) nM and 0.108 (±0.06) μM.  
This interaction is both enthalpically (dH1 is -1.61 ± 0.46 KJ/mol and dH2 is -0.52 ± 0.5 
KJ/mol) and entropically favorable (dS1 is 144 ± 21.51 J/mol.K and dS2 is 81 ± 78.17 J/ 
mol.K).  Binding of holo Yfh1WT to YIsu1 mutant E144A demonstrated a heat release 
pattern that was similar to the control experiment.  Subtraction yielded a flat line with no 
measurable affinities or thermodynamic parameters (data not shown).  In contrast, 
binding of both: the mutant D145A and the double mutant E144A, D145A yielded an 
endothermic pattern of heat release and were best fit with a multiple sites binding model 
with a total binding of approximately one molecule.  The D145A mutant showed 
approximately a thirty-fold decrease in binding affinities at both sites compared to YIsu1 
WT of 95.2 (±78) nM and 2.91 (±2.54) μM at the second site.  This interaction though 
not enthalpically favourable (dH1 is 1.01 ± 0.13 KJ/mol and dH2 is 1.63 ± 0.67 KJ/mol) 
was entropically favorable (dS1 is 139 ± 6.93 J/mol.K and dS2 is 113 ± 6.36 J/mol.K).  
The E144A, D145A double mutant showed binding affinities that were decreased, but to 
a lesser extent as compared to the D145A mutant with KD values of 51.5 ± 15.4 nM at 
one site and 0.85 ± 0.02μM at the second site.  Again, as in the case of the D145A 
mutant, this interaction was not enthalpically favorable (dH1 is 2.45 ± 0.07 KJ/mol and 
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dH2 is 1.26 ± 0.18 KJ/mol) but was entropically favorable (dS1 is 148 ± 2.83J/mol.K and 
dS2 is 120 ± 0.85 J/mol.K). 
 
	  3.5.5 YIsu1 mutant shows altered Fe-S assembly activity: 
Protein bound 2Fe-2S clusters yield a characteristic signature spectrum in the 
near UV region (300-700 nm) using circular dichroism [30].  Owing to its sensitivity, this 
technique was employed to test the ability of WT YIsu1 and the D145A mutant to 
synthesize clusters: either in the presence of holo Yfh1WT or just Fe(ll) alone.  A 
previously published protocol [31] was modified such that the reaction mixture contained 
100 μM WT YIsu1 or D145A mutant, 200 μM holo-Yfh1 (prepared as mentioned above) 
or 200 μM Fe(ll) alone.  The reaction was initiated by adding 1 mM Na2S in a final 
volume of 1.2 mL.  The concentration of Na2S was optimized to minimize contamination 
by a ferrous sulfide species that forms upon mixing.  Controls containing either holo-
Yfh1 or Fe (ll) alone mixed with Na2S in buffer and in the absence of YIsu1 was tested 
and yielded no characteristic spectrum (data not shown).  The mixture was slowly 
agitated by stirring with a magnetic stir bar for 30 seconds in between data collections.  
A set of two scans were collected over 10 minutes and averaged.  Data was collected 
for approximately 100-120 minutes or until signal saturation was observed.  In Figure 
3.5, panel A shows the activity plot of WT YIsu1 and panel B shows the activity plot of 
the YIsu1 D145A mutant in the presence of holo Yfh1WT ()  and Fe(ll) alone ().  In the 
inset are displayed the CD data  
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Figure 3.6: Fe-S assembly activity of WT YIsu1 and mutant D145A: on YIsu1 
WT (A) or the D145A mutant (B) by near UV circular dichroism.  The solution 
contained 100 μM YIsu1 protein in 20 mM HEPES (pH: 7.5) 150 mM NaCl 5 mM 
β-Me buffer to which 100 μM Fe (ll) was added either as holofrataxin ( and inset 
panel ‘a’) or alone (wand inset panel ‘b’).  Reaction progress was monitored from 
300-700nm over time until saturation.  CD data at 435nm was plotted over time to 
obtain activity plots.  Error bars represent average values at each time point from 
two independent reproducible experiments collected.  	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collected in the presence of holo Yfh1 WT, panel ‘a’ and in the presence of Fe(ll) alone, 
panel ‘b’.  In the presence of holo Yfh1 WT, YIsu1 shows activity that is approximately 
two fold higher than its activity in the presence of Fe(ll) alone.  The reaction with 
Frataxin also appears to proceed at a faster rate compared to that with Fe(ll), evident 
from the initial phase of the reaction (initial 20 mins.)  which occurs on a shorter time 
scale. This clearly indicates a stimulation of YIsu1 WT activity in the presence of holo 
Yfh1WT.  In contrast, the D145A mutant showed a higher activity in the presence of Fe 
(ll) alone.  The reaction, although slower was more active in the synthesis of clusters 
than the reaction with Frataxin alone which reached saturation earlier.  This 
phenomenon could be due to diminished interaction of the D145A mutant with Yfh1WT 
and altered energetics associated with the synthesis of Fe-S clusters. 
 
3.6 Discussion: 
There has been much speculation over the role of Frataxin in the ISC multiprotein 
complex.  So far, its functions that have been described include a role as the Fe 
chaperone for iron-sulfur cluster synthesis where it functions in delivering iron to ISU for 
cluster assembly [8, 31, 32] and as a modulator of the cysteine desulfurase enzyme in 
Fe-S assembly [33].  Frataxin and ISU are known to be stable binding partners within 
and outside of the ISC complex [8, 10, 32-34].  This interaction has been demonstrated 
both genetically and in vitro and has been shown to be iron dependent [8, 35].  
However, the initial events of Fe acceptance by ISU and its subsequent incorporation 
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into Fe-S clusters are yet unclear. In this study we further examine the interaction 
between Frataxin and ISU with a focus on ISU.  Unpublished XAS and Mössbauer 
results from our lab carried out on four ISU orthologs namely yeast, human, fly and 
Thermatoga all show that Fe (ll) is bound in a 6-coordinate oxygen/nitrogen ligand 
environment [8] indicating that the Fe delivery/acceptance occurs at a site that is 
different from ISU’s cysteine rich active site. The presence of alternative metal binding 
and substrate binding sites on the same protein has previously been described for 
Ferrochelatase, the enzyme that inserts Fe into heme [21].  ISU is a molten globule 
protein with a hydrophobic interior and it has been previously described that the 
synthesized Fe-S cluster is buried within a solvent inaccessible region in the 
multiprotein complex [8] possibly precluding a release of reaction intermediates that 
may endanger the mitochondrion.  Under such circumstances, the occurrence of a 
separate metal binding site in a region that is accessible to solvent and/or protein 
binding partners is feasible.  The assembly of Fe-S clusters by ISU involves changes in 
fold within the protein.  The Markley group has demonstrated that bacterial IscU exists 
in an equilibrium between structured (S) and disordered (D) states and that the (D) state 
is the substrate for cysteine desulfurase binding [22].  Using fluorescence anisotropy, 
research from our group has reported structural changes in yeast Isu1 upon binding of 
Fe and S2- [8]. These results indicate that substrate binding drives structural changes in 
ISU. This fact has been further corroborated by the crystal structure of IscU from the 
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bacterium A. aeolicus which shows an increase in order of fold of the C-terminus upon 
cluster assembly [20]. 
In this study we replaced conserved, charged residues E144 and D145 on 
YIsu1’s C-terminal helix with an uncharged alanine residue by site directed 
mutagenesis.  We have previously shown by NMR that charged residues on frataxin’s 
α1/β1 acidic ridge along with a portion of its β-sheet forms the interface of frataxin with 
ISU [8].  These regions also include frataxin’s Fe binding residues [36].  A closer look at 
the IscU-IscS crystal structure from the Cygler group shows that IscU interacts with IscS 
in the proximity of its active site, leaving the c-terminal helix open and solvent exposed.  
Predictive modeling of CyaY on the IscU-IscS structure showed that CyaY possibly 
binds IscS in a region close to the IscU binding site and appears to be in a region that 
also overlaps the IscU C-terminus [9].  Charged residues on IscU’s c-terminus would 
provide a complementary charged binding surface to frataxin promoting electrostatic 
interactions that could aid Fe delivery. 
Far UV circular dichroism did not show major deviations in secondary structure 
between the wild type protein and mutants.  Compared to the wild type protein, the 
E144A and D145A single mutants both showed a slight increase in helical content of 6% 
and 3% respectively with a corresponding drop in β–sheet content indicating a 
possibility that these mutants have a greater helical fold compared to the WT protein 
and that in the WT protein, these mutants possibly destabilize the C-terminal helix.  The 
fact that the E144A mutant stabilizes the protein fold has been previously shown by the 
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Markley group in bacterial IscU (corresponding residue E111A) [22]. A double mutation 
in the area appears to restore WT folds as indicated by the E144A, D145A mutant.  
Competition binding assays with Mag-fura-2, used to test the Fe(ll) binding ability 
of WT YIsu1 and mutant proteins showed binding affinities in the micromolar range for 
both sites. Using isothermal titration calorimetry, we observe nanomolar to micromolar 
binding affinities when YIsu1 binds Fe(ll) [8]. As ITC measures total heat, we speculate 
the occurrence of contributions from heats due to conformational changes on Isu in 
addition to heat released upon Fe(ll) binding.  As the mutant proteins all showed a drop 
in binding affinities at one of the sites with the second site being only marginally 
affected, we can conclude that these residues are possibly involved in Isu’s initial iron 
binding site.  
The thermal stability and associated energetics of the apo- and holo-forms of WT 
and mutant proteins were also tested by differential scanning calorimetry.  Melting 
curves of the apo forms of both WT and mutant proteins showed two distinct transition 
temperatures, which could possibly correspond to denaturation of the structured and 
disordered forms of the protein [22]. The holo form of WT YIsu1 alone could be fit with a 
single transition state indicating almost 100% shift to a higher, single melting 
temperature brought about by a stabilizing change in protein structure accompanied by 
Fe(ll) binding.  The melting of the protein at two distinct temperatures during 
denaturation has been recently reported by the Pastore group in as-purified bacterial 
IscU at a 30 fold EDTA excess, in addition, a stabilizing change accompanied with a 
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shift to a higher melting upon Zn binding was also shown [37]. Among the mutant 
proteins, apo D145A melted at a temperature similar to WT, while the holo form 
underwent a destabilizing change upon Fe(ll) binding evident by a shift to lower melting 
temperature. The E144A mutant was intrinsically more stable, the apo form melted at a 
temperature that was three degrees higher that WT. Holo E144A appeared to be in 
equilibrium between two stable states, one at a temperature similar to holo WT YIsu1 
and another at a higher temperature.  As previously described, the E144A mutant has 
been described as a mutant that stabilizes the S-state [22], which possibly is a reason 
for the observed higher than WT stability. The apo form of the E144A, D145A mutant 
had a lower stability than WT, however Fe(ll) binding was associated with a stabilizing 
switch to higher temperatures in a manner similar to the E144A single mutant possibly 
reflecting the stabilizing change observed in the single mutant.  These results clearly 
indicate a stabilizing change in YIsu1 structure upon substrate, Fe(ll) binding.  In 
addition, the inability of the D145A mutant to make the switch to a more stable fold 
would implicate this residue in in metal binding.  Thermodynamic parameters associated 
with the unfolding of WT YIsu1 showed that denaturation of holo WT YIsu1 was not 
accompanied by any significant changes in enthalpy and entropy indicating that the 
structural change possibly balanced out energetic changes associated with Fe(ll) 
binding.  The denaturation of apo D145A was associated with an increased enthalpy 
compared to apo WT indicating a possible intrinsic change within the protein structure.  
However, the denaturation of the holo forms of all the mutant proteins was accompanied 
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by significant increases in both enthalpy and entropy indicating an enthalpically 
unfavorable yet entropically favorable process, distinct from WT YIsu1.  
The holo Yfh1WT binding ability of WT YIsu1 and mutant proteins was also 
tested by isothermal titration calorimetry.  Binding of WT YIsu1 to holo Yfh1WT was 
associated with much tighter binding affinities than those previously published for Fe(ll) 
alone [8], indicating a strong binding interaction with holo Yfh1WT.  Binding affinities, 
unlike the UV-Vis method were of two distinct types: a tighter nanomolar affinity and a 
lower micromolar affinity.  Compared to WT, binding of mutant proteins D145A and 
E144A, D145A was associated with a decrease in binding affinity of up to 30-fold in the 
D145A mutant and approximately 20-fold in the double mutant at the higher affinity site.  
The lower affinity site was also associated with decreased affinities, however to a less 
severe extent.  In addition, decreased binding affinities were associated with a decrease 
in stoichiometry of binding indicating a weak interaction.  For E144A binding to holo 
Yfh1WT, the binding isotherm was similar to the buffer control yielding no measurable 
binding affinity upon buffer subtraction.  Mutant proteins D145A and E144A, D145A 
binding holo-Yfh1 followed an endothermic trend as opposed to the exothermic trend 
observed with WT YIsu1 binding.  Associated changed with thermodynamic parameters 
were also observed.  WT YIsu1 binding holo Yfh1 was enthalpically favorable however 
mutant binding to holo frataxin was associated with a rise in enthalpy i.e. was an 
enthalpically unfavorable change.  Entropy and free energy values for both WT and 
mutant YIsu1 however, remained similar.  These results indicate a) that holo Yfh1WT 
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binding is an enthalpically favorable process possibly characterized by electrostatic 
interactions and hydrogen bonding, an enthalpically favorable process has also been 
described for holo Drosophila frataxin binding Isu1 [31] and that b) these residues, 
particularly the D145A mutant is required for both Fe binding, and holo-Yfh1 interaction, 
possibly forming the interface between Yfh1WT and WT YIsu1 and c) mutations at 
these regions are associated with a change in thermodynamic properties associated 
with Fe(ll) binding that are enthalpically unfavorable.  
Finally, the ability of WT YIsu1 and the D145A mutant to synthesize clusters was 
tested by time course far UV circular dichroism spectroscopy in the presence of either 
Fe(ll) alone or holo Yfh1WT. WT YIsu1 showed a twofold increase in cluster synthesis in 
the presence of holo Yfh1WT, indicating a direct stimulation of YIsu1 activity in keeping 
with its role as an Fe chaperone. In contrast, the D145A mutant showed an increase in 
activity in the absence of holo Yfh1WT, though the reaction progressed at a slower 
pace.  Fe(ll) binding experiments showed a decrease in affinity at one site while the 
second site which is possibly the active site, appeared to retain binding properties which 
could explain the ability of the mutant to synthesize clusters.  ITC experiments of holo-
Yfh1 binding to the D145A mutant showed a weak interaction with altered energetics 
associated with binding.  In the presence of holo Yfh1, the reaction with D145A reached 
equilibrium faster possibly due to saturation of the active site by additional interactions 
mediated by frataxin.  In the absence of frataxin, one can envision the active site being 
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populated at a slower pace in the absence of the initial binding site hence, saturates 
later.   
These results lead us to postulate a model for the initial binding events of Fe-S 
cluster assembly. 
1) Holo-frataxin appears to activate Fe-S assembly therefore an iron dependent 
interaction between frataxin & ISU appears to be essential for efficient cluster 
synthesis. 
2) Initial metal binding is facilitated by electrostatic interactions between charged 
residues at the interface of holo-frataxin and ISU at Isu’s c-terminus, and is an 
enthalpically favorable process.  The D145A residue appears to play a critical 
role in this process. 
3) This is followed by a structural change in ISU that possibly favors hydrophobic 
interactions within the protein and facilitates Fe-S synthesis.  
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CHAPTER 4 
DROSOPHILA FRATAXIN CRYSTAL STRUCTURE, RESONANCE ASSIGNMENTS 
AND PUTATIVE IRON BINDING RESIDUES 
 
 
4.1 Prelude 
Friedreich’s ataxia (FRDA) is caused by a patient’s inability to produce a viable 
form of the mitochondrial protein frataxin.  Frataxin’s involvement in cellular iron 
regulation became evident by the observed accumulation of large amounts of iron in 
actively metabolizing cells of individuals suffering from FRDA.  Frataxin has since been 
shown to participate in several capacities related to regulating cellular iron homeostasis: 
as an iron chaperone for iron-sulfur cluster and heme synthesis, as a modulator of 
protein partners in the Fe-S cluster assembly pathway and as an iron storage protein 
within the mitochondria in a manner similar to cytosolic Ferritin but, only under 
conditions of oxidative stress. Analysis of the activity and structure of two eukaryotic 
frataxin orthologs (yeast and human) has been constrained by autodegradation and 
aggregation.  In contrast, the Drosophila frataxin homolog (Dfh) is stable making it a 
perfect molecule for structure based functional characterization studies.  
 In this report, we describe the crystal structure and NMR assignments of apo 
Dfh.  In addition, using nuclear magnetic resonance (NMR) spectroscopy, we report 
potential Fe(ll) binding residues on this protein.  A previous graduate student (Dr. Swati 
Rawat) who completed backbone chemical shift assignments for Dfh, initiated this work.  
My contributions include sample preparation, 15N HSQC data collection and processing, 
and development of the crystallization for the apo-protein.  Contributors include Dr. 
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Joseph Brunzelle (APS, Argonne National Laboratory) who crystallized Dfh and solved 
the structure, Lindsey Thompson and John Rotondo who aided with protein purification 
and Jefferson Plegaria (Pecoraro lab, University of Michigan) who aided with NMR data 
processing.  The text below is being prepared for publication in the journal Biochemistry. 
 
4.2   Abstract: 
 Friedreich’s ataxia, the most prevalent hereditary ataxia is caused by a patient’s 
inability to produce a viable form of the protein frataxin [1-3].  Frataxin is a nuclear 
encoded protein transported to the mitochondrial matrix [1, 4] and believed to serve as 
an iron chaperone/regulator of the Fe-S cluster (ISC) assembly pathway [5-9].  
Frataxin’s role as an iron chaperone is controversial and atomic details of its interaction 
with partner proteins are still unknown.  While the in vitro studies on the human and 
yeast orthologs have been plagued by the poor stability of the proteins, the Drosophila 
homolog appears to resist autodegradation.  Thus, a structural clarification of Dfh would 
serve as a useful starting point for further studies into the molecular and atomic details 
of frataxin’s function at a molecular level.  With this goal in mind, we report the crystal 
structure of Dfh, nearly complete NMR chemical shift assignments of the mature apo-
protein and the identification of Dfh iron binding residues, obtained by NMR.  The crystal 
structure of the mature apo-Dfh suggests the protein is well folded with an alpha/beta 
sandwich motif structure in agreement with the published structures for related orthologs 
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[6, 10-12].  This work provides a starting point for further characterization of metal 
binding and partner protein interaction sites in the stable fly system. 
 
4.3 Introduction: 
 Friedreichʼs ataxia (FRDA), a cardio- and neurodegenerative disorder affecting 1 
in 50,000, is caused by an inability to produce the mitochondrial protein “frataxin” [1].  
Protein deficiency in FRDA patients is typically the result of an atypical GAA 
trinucleotide intronic expansion in the frataxin gene that disrupts transcription, although 
a subset of patients have frataxin single point mutations [3].  Phenotypes of the disorder 
include Fe-S cluster (ISC) deficiency, as well as mitochondrial iron overload coupled to 
cell death.  This is a result of reactive oxygen species (ROS) induced oxidative stress 
that occurs when the iron chemistry within the mitochondria is unregulated [13, 14].  
Current treatment strategies for the disorder have suffered due to a lack of specific 
knowledge regarding the exact role frataxin plays in regulating cellular iron homeostasis 
[15].  Such functional knowledge at the molecular level would be extremely beneficial, 
since it would provide an additional focal point to target new alternative drug treatment 
strategies.     
A large amount of work in the frataxin field has been performed using the yeast 
and human model systems.  These studies have revealed valuable insight into the 
biochemistry of the protein and its role in the molecular pathogenesis of FRDA [6, 16-
19].  However, FRDA research has suffered due to deficiencies in the proteins within 
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these model systems.  Instability of human frataxin with N-terminal autodegradation and 
the high susceptibility for oxidation induced protein aggregation in the yeast ortholog 
has plagued studies with both eukaryotic proteins [10, 20, 21].  Recently, our laboratory 
fortuitously discovered that the frataxin homolog from Drosophila melanogaster (Dfh) is 
much more stable than the other orthologs [8]. Thermal denaturation profiles showed 
that Dfh melted at a temperature of 590C, compared to Yeast ortholog which melted at a 
temperature of 440C [8].  Greater stability would make the fly system a perfect model for 
structure/function characterization. 
 In addition to issues of protein stability, Dfh makes an excellent model system for 
studying frataxin function since Dfh shares a high degree of sequence homology with 
other frataxin orthologs (for example, 53% with the human protein) [22].  It also plays a 
direct role in controlling cellular oxidative stress, with activity towards aconitase repair 
and stability [23-26].  Under anaerobic conditions, Dfh exists as a stable iron-loaded 
protein monomer which is arguably the functional form of the protein under normal 
cellular conditions.  We have shown Dfh prevents reactive oxygen species-induced 
oxidative damage to DNA in the presence of both Fe (II) and H2O2, so the protein has 
additional functions beyond possible iron delivery.  Finally, the fact that Dfh mediates 
Fe(II) delivery to yeast Isu, promoting Fe-S cluster assembly in vitro in the process, has 
implications for protein activity (and the potential for teasing out mechanistic details) 
between species [8].  Given the direct correlation between frataxin’s function and ISC 
biosynthesis, the fly model could therefore be exploited to provide real insight into Fe-
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cofactor bioassembly.  
In this report we compare the structures of human, yeast and fly frataxin 
orthologs, which are similar in fold and function, but exhibit subtle differences which 
possibly form the basis for the extraordinary stability of Dfh.  Finally, we identify Dfh 
residues that may play a role in iron binding. 
 
4.4 Materials & Methods: 
4.4.1 Labeling, expression, and purification of Drosophila Frataxin 
 The Dfh construct was expressed in the E. coli BL21 (DE3) strain transformed with 
a modified pET 101/D-TOPO vector DNA.  15N-labeled and 13C/15N doubly labeled 
Drosophila frataxin, spanning amino acids 59–190, were obtained from bacteria grown 
in M9 minimal medium with 15NH4Cl and 13C6 D-glucose as the sole nitrogen and carbon 
sources, respectively.  Unlabelled protein was overexpressed and isolated from bacteria 
grown in Luria-Bertani broth.  For unlabelled protein expression, cells were grown at 
37°C followed by induction at OD600 of 0.6 with 1 mM IPTG for 6 hours.  For labeled 
protein expression, as cells grew at a slower pace in minimal media, growth was 
continued overnight (16-18 hrs.) at 250C and then harvested.  Cell pellets were stored at 
-800C until use.  
All protein isolation steps were carried out at 40C.  Cell pellets re-suspended in 
buffer containing 25 mM TRIS (pH: 8.0), 10mM EDTA, 5 mM β-Me (5 ml buffer/g cells) 
in the presence of lysozyme (100 μg/μl), complete EDTA free protease inhibitor (1 
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tablet/ 50 ml, Roche), DNAse (10 μg/ml) and MgCl2 (5 mM) were allowed to incubate for 
~15mins.  Cells were lysed by three passes through a high-pressure homogenizer 
(Emulsiflex C3, Avestin) and centrifuged at 21,000 rpm for one hour.  The supernatant 
was separated and filtered through a 0.2 μm filter and the crude soluble fraction was 
subjected to two ammonium sulfate precipitation steps: salting in at 40% ammonium 
sulfate followed by recovery of supernatant, and precipitation at 65% ammonium sulfate, 
followed by resolubilization in lysis buffer. This partially purified preparation was then 
dialyzed twice against a 1:200 volume dilution of Buffer A (25 mM Tris-HCl (pH: 8.0), 10 
mM EDTA, 5 mM β -Me) for a minimum of 6 - 12 hours at 40C with one buffer change in 
between to remove Ammonium Sulfate.  Following dialysis, protein was filtered and 
subjected to anion exchange chromatography using a Q-Sepharose column 
(Pharmacia) equilibrated in Buffer A, and eluted using a salt gradient made with buffer B 
(25 mM Tris-HCl (pH: 8.0), 10 mM EDTA, 1 M NaCl, 5 mM β-Me) up to a final 
concentration of 1 M NaCl.  Dfh eluted at a sodium chloride concentration of 500 mM.  
Fractions containing Dfh were pooled and dialyzed against buffer A to remove NaCl.  
The dialyzed protein was then made up to 1 M Ammonium Sulfate, filtered and loaded 
onto a Phenyl-Sepharose column (Pharmacia) using Buffer A and a reverse 1 M 
ammonium sulfate gradient in Buffer C (25 mM Tris-HCl (pH:8.0), 10 mM EDTA, 1M 
Ammonium Sulfate, 5 mM β-Me).  Dfh eluted at 800 mM ammonium sulfate.  Fractions 
containing Dfh were pooled and concentrated to 1 ml followed by a final purification step 
by size-exclusion through a Sephacryl-75 column (GE) equilibrated with 20 mM HEPES 
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(pH 7.5), 150 mM NaCl, 5 mM β-Me.  Dfh eluted at a volume corresponding to a 
monomer [8].  Isolated protein was concentrated and stored anaerobically in a glove box 
(Coy Labs) at 40C or flash frozen in liquid nitrogen and stored at -800C.  Typical yields 
were 50mg/L of growth medium. 
 
4.4.2 Crystallization and determination of apo-Dfh structure: 
Purified unlabelled apo Dfh at  ~2 mM concentration in 20 mM HEPES (pH: 7.5) 
150 mM NaCl and 5 mM β-Me (Figure 4.1) was crystallized and the structure was 
solved in collaboration with Dr. Joseph Brunzelle at the Advanced Photon Source, 
Argonne National Laboratory.  
Crystals of native Dfh were obtained by sitting drop vapor diffusion by mixing 1:1 
ratio of 7.2 mg/mL protein with 0.1 M citric acid (pH 5.0) and 1.6 M ammonium sulfate 
grown at 20ºC. Crystals were harvested, soaked in the mother liquor with 25% glycerol 
and flash frozen in liquid nitrogen.  Data were collected on the 21-ID-G beam line (LS-
CAT Sector-21) at the Advanced Photon Source (Argonne National Labs, Argonne IL).  
A 1.405 Å data set was processed and scaled with autoPROC [27].  The structure was 
solved by molecular replacement using PHENIX autoMR [28] with the atomic 
coordinates of 1EKG, which was further built and refined manually using Coot [29] and 
Phenix refine with TLS refinement [30], respectively.  The final model was validated in 
MolProbity [31]. Data collection and refinement statistics are provided in Table (4.1). 
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Figure 4.1: SDS-PAGE gel showing Dfh purity.  Unlabelled Dfh samples were 
run on an SDS-PAGE gel after purification through a phenyl sepharose column.  
The lane to the extreme right represents the protein marker and the lanes to the 
left represent Dfh at varying concentrations.  Protein obtained was >95% pure 
and was used for crystallization. 	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Table 4.1: Dfh crystallography data collection & refinement statistics. 
Data collection 
    Wavelength (Å) 0.979 
    Space group C2 
    Cell dimensions (Å) a = 78.90, b = 38.51, c = 46.30, β = 123.45° 
    Resolution (Å)a 37-1.405 (1.41-1.405) 
    Observed reflections 74,124 
    Unique reflections 21,840 
    Rmerge (%)a,b 3.7 (32.8) 
    Multiplicitya 3.4 (2.1) 
    Completeness (%)a 95.9 (75.6) 
 
Refinement statistics  
    Resolution range (Å) 37–1.405 
    Rfactor (%)c 15.24 
    Rfree (%)d 17.39 
    No. of protein atoms 1986 
    No. of non-protein atoms 10 
    No. of water molecules 140 
    Molprobity score 3.92 
    Ramachandran plot (%)e 97.0/3.0/0.0 
    Average B factor (Å2)   
        Protein 20.9 
        Non-Protein 46.2 
        Waters 31.4 
        Overall 21.7 
    RMSDs  
        Bond lengths (Å) 0.008 
        Bond angles (º) 1.191 
  a The values in parentheses are for the highest resolution shell.  b Rmerge = Σhkl Σi|I(hkl)i − 
<I(hkl)>|/Σhkl Σi I(hkl)i, where I(hkl) is the intensity of reflection hkl, and <I(hkl)> is the average 
intensity over all equivalent reflections.  c Rfactor = Σ||Fo| − |Fc||/|Fo|, where |Fo| and |Fc| are the 
observed and calculated structure factor amplitudes, respectively. d Rfree is the same as the 
Rfactor but for a 5% subset of all reflections that were not used in the refinement.  e 
Core/allowed/disallowed.  
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4.4.3 NMR Spectroscopy on Apo and Holo Dfh: 
 NMR spectra were acquired at 298 K on a Varian INOVA 720 MHz spectrometer 
(National High Field Magnet Laboratory, Tallahassee FL) and on a Varian INOVA 600 
MHz spectrometer (Wayne State University).  The 720 MHz spectrometer was equipped 
with a triple resonance gradient room temperature probe while the 600 MHz 
spectrometer utilized a Varian triple resonance gradient cold probe.  Frataxin samples 
used in the backbone assignments were prepared at 1.2 mM concentration in NMR 
buffer (20 mM HEPES, 150 mM NaCl, pH 7.5, 90% H2O /10% D2O).  Backbone 
assignments were made using the following experiments: 15N-HSQC, HNCO, HNCACB 
and CBCA(CO)NH [32]. HNCACB spectra provide Cα and Cβ chemical shifts for the 
amino acid of interest, as well as from the residue immediately N-terminal in the 
protein’s sequence.  CBCA (CO) NH spectra are used to verify chemical shifts of the N-
terminal residue.  When combined, these data allow one to make sequential 
assignments for the backbone of a protein.  All spectra were analyzed according to 
established lab protocols [6] using the processing programs NMRPipe [33] and nmrView 
[34].  CSI analysis was performed using a program provided by nmrView using 
backbone Cα, Carbonyl carbon and Nitrogen atoms only.  Secondary structure 
prediction based on backbone atom chemical shift suggests that mature Dfh contains 2 
alpha helices and 6 beta sheets in agreement with that of the crystal structure. 
NMR amide chemical shift perturbation experiments were used to identify amino 
acids affected by the presence of iron under solution conditions that stabilize the 
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monomeric iron loaded Dfh protein.  15N labeled apo Dfh protein at ~0.7 mM 
concentration was prepared in the NMR buffer listed above: 20 mM HEPES (pH 7.5) 
150 mM NaCl 5 mM β-mercaptoethanol, 90%H2O/ 10% D2O.  Protein sample was pre-
incubated in the glove box overnight at 40C followed by transfer to NMR tubes, which 
were sealed with airtight septa.  Ferrous ammonium sulfate was also prepared 
anaerobically within the glove box in the NMR buffer.  For the holo Dfh sample, ferrous 
ammonium sulfate at a concentration of 6mM was anaerobically titrated in 70 uL 
volumes into the protein, to a final concentration of 1:1 Dfh to Fe(ll).  Protein 
concentration after addition of Fe(ll) was ~0.63 mM.  Spectra were collected on a Varian 
INOVA 600 MHz spectrometer under conditions identical to backbone assignment 
experiments outlined above.  Samples were allowed to equilibrate to 25 0C within the 
spectrometer prior to data collection.  Full 1H/15N heteronuclear single quantum 
coherence (HSQC) spectra were collected at each titration point using a 1H sweep width 
of 7804 Hz (2048 points and 64 transients) and a 15N sweep width of 2500 Hz (512 
increments).  Spectra were transformed as mentioned above using NMRPipe and peak 
positions were calculated using SPARKY [35].  
 
4.4.4 Assignments and data deposition 
 Residue assignments for the mature (59-190) Drosophila frataxin protein are 
provided in the high-resolution 15N-HSQC spectrum for the protein (Figure 4.4).  Full 
backbone assignment was achieved for 128 out of 133 residues.  Five proline residues 
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in the protein remain unassigned.  For further reference, the residue sequence for full-
length Drosophila frataxin can be found at http://www.uniprot.org/uniprot/Q9W385.  
Chemical shift assignments are deposited in the Biological Magnetic Resonance Bank 
(http://www.bmrb.wisc.edu/) under the accession code BMRB- 17135. 
 
4.5 Results: 
4.5.1 Crystal structure of Drosophila Frataxin homolog (Dfh): 
Crystallographic results indicate that Dfh has an overall fold that is highly similar 
to the characterized ortholog structures [21].  The protein has an alpha-beta sandwich 
motif comprising two α-helices that form one plane, with a succession of five β-strands 
that are sandwiched between the α-helices forming the second plane of the molecule 
[21].  A sixth β-strand intersects the two planes, thus forming the characteristic α-β 
sandwich motif that is shared between the frataxin family of proteins (Figure 4.2 A). The 
number of β-strands is variable between orthologs: yeast frataxin and the bacterial 
homolog CyaY have six β-strands while a seventh strand has been reported only in the 
human ortholog [21]. Sequence identity between proteins measured by clustal-ω 
sequence alignment are 54% and 38% with the human and yeast proteins respectively 
and 22% with the bacterial homolog CyaY (Figure 4.3).  RMSD values between Dfh and 
orthologs in regions of secondary structure are 1.13 Å and 1.44 Å respectively with the 
human and yeast orthologs (measured using the ‘align’ tool on PyMoL [36]).
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Figure 4.2: The crystal structure of Drosophila frataxin homolog Dfh. (A) Ribbon structure and (B) Surface 
electrostatic potential plots for Dfh at three different orientations around the vertical axis.  (A) Labels for the different 
secondary structural elements are marked adjacent to the corresponding helix or strand.  (B) To the left is a surface 
electrostatic potential plot for Dfh at an orientation that corresponds to the ribbon structure.  Electrostatic surface 
plots were calculated using the free PDB2PQR software* and modeled with the APBS plugin* for PyMoL using a 
solvent radius of 1.4 Å and a contour value of 10 kT/e for both charged isoforms.  Secondary structural landmarks 
on the rotated structures are labeled for clarity.  **[37, 38] 
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Figure 4.3: Clustal-ω sequence alignment between Frataxin orthologs: D. 
melanogaster (Dfh), H. sapien (HsFtx), S. cerevisiae (Yfh1WT) and E. coli (CyaY).  Fully 
conserved residues are indicated by an asterisk (*) under the residue. 
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Structural instability associated with the human and yeast frataxins have been 
attributed to their relatively unfolded N-terminus, prior to the helix-1, which leads to 
protein autodegradation [21].  Mature human frataxin extends from residue 75-210 with 
a total of 18 N-terminal residues and [10, 20], mature yeast frataxin spans residues 52-
174 [6] and, like the human ortholog has 18 N-terminal residues. On the other hand, the 
structure of Dfh spans residues 65-190 and appears to have a relatively short unfolded 
N-terminus comprising 5 residues only (Figure 4.2 A).  In addition, frataxin’s C-terminal 
residues past the helix-2 have been reported to be an additional determinant of protein 
stability.  Melting temperature studies on yeast frataxin correlated a longer C-terminus to 
greater stability [21].  Human frataxin has a relatively long C-terminus of 16 residues, 
while the yeast ortholog has only 3 residues terminal to helix-2.  The C-terminus of Dfh 
on the other hand comprises 18 residues, a part of which appears to be folded into a 310 
helix and in addition, makes contact with helix-1 possibly providing added stability.  A 
combination of a relatively shorter N-terminus with a longer C-terminus, both of which 
are attributes to greater stability are possibly factors that contribute to the resistance of 
Dfh to degradation. 
Figure 4.2 (B) shows the electrostatic surface plot of Dfh.  The red region that 
spans the first α-helix and first β-strand region represents the acidic patch that consists 
of conserved, surface exposed acidic residues.  This acidic patch is common to frataxin 
proteins and has been identified to be crucial for frataxin’s iron binding ability and 
interaction with partner proteins [21].  
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4.5.2 Dfh backbone resonance assignments: 
 In order to exploit structural information regarding Dfh, we present the assignment 
of the backbone atom chemical shifts, obtained by Nuclear Magnetic resonance (NMR) 
spectroscopy, in this report.  Dispersion of amide resonances in the 15N HSQC spectra 
of the 59-190 residues of fly frataxin construct (Figure 4.4) confirm the majority of 
residues exist in a structured region.  In order to avoid referencing errors, LACS (Linear 
Analysis of Chemical Shift) analysis of the protein residues was performed.  LACS 
analysis is used to detect the referencing errors.  Linear regression plots between the 
secondary shifts of the alpha and difference between the secondary shifts of the alpha 
and beta carbons for residue ‘i’ of protein pass through the origin from two directions, 
suggesting correct referencing.  A total of 128 out of 133 residues of the mature Dfh 
protein were assigned.  The structure of Dfh was predicted using the Chemical Shift 
Indices (CSI) program based on the backbone atom assignments.  CSI is a program 
that predicts protein’s secondary structure.  CSI measures the deviation of the obtained 
chemical shift value assigned to each backbone atom in the molecule of interest to 
values from an averaged library for atoms in a random coil, helix and strand.  The sign 
and magnitude of these deviations can then be used to correlate the predicted 
secondary structure type that the residue is found in, providing a rough estimate of the 
probable secondary structure profile of the molecule from just the chemical shift 
assignments.  Prediction of secondary structural elements for Dfh in solution using 
chemical shift indices (CSI) analysis within the program nmrView [34]  
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Figure 4.4.  Assigned 15N HSQC spectrum of Dfh.  Data was collected on the 
National Magnet Laboratory’s Varian INOVA 720 MHz spectrometer at 298 K and at in 
house INOVA 600 MHz 
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suggests the protein secondary structural elements are highly conserved between 
orthologs, and the structure most likely exists as an α/β sandwich motif family member 
(Figure 4.5).  The predicted Dfh secondary structure lacks the N-terminal 310 helix 
observed in the yeast frataxin structure [6] but it shows the presence of a beta strand 
before the helix-1, suggesting the Dfh structure is little different than the human frataxin 
N-terminal extension protein [11, 39].  Based on the predicted structural regions of the 
protein using the highly reliable Ca, N and CO data, the structure of Dfh consists of 
helices formed by the [residues 13-37 (H1) and 108-120 (H2)] and seven β-strands 
covering residues 10-12 (S1), 46-48 (S2), 53-57 (S3), 72-74 (S4), 77-79 (S5), 88-93 
(S6) and 96-100 (S7).   
 The CSI predicted structure of Dfh suggests that it consists of 27% beta strand and 
36% helical content.  Based on this predicted structure Isu binding residues on the Dfh 
structure were determined.  In case of yeast frataxin (Yfh1), the Isu binding residues 
have been assigned.  The corresponding residues of Dfh include Glu 32, Thr 35 (lie on 
helix 1 region); Val 52, Leu 53, Thr 54, Val 55, Leu 57 (lie on beta sheet 1 surface); Gln 
105, Gly 117 and Ser 119 (lie on loop and helix 2 surface).  Thus most of the 
functionally important residues of frataxin lie on the same region on predicted protein as 
in case of yeast frataxin. 
 The backbone atom chemical shift assignments of Dfh provides a control for 
future experiments directed at monitoring structural changes on the protein coupled with 
Fe (II) and partner protein binding.  Using the predicted secondary structure model, we  
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Figure 4.5.  Summary of proposed secondary structural elements for Dfh: based 
on A) Cα, B) Cβ, C) Carbonyl carbon and D) N, in solution obtained from CSI analysis 
using NMRView.  Single letter residue designations are provided (top) with predicted 
secondary structural elements displayed in red (helix), blue (strand) or grey (unfolded).  
 
A	  
B	  
C	  
D	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Figure 4.6.  Consensus secondary structure prediction. This structure is predicted 
using the secondary structure prediction for Cα, N and Carbonyl carbon. Prediction is 
made manually by using consensus where two of the three values points the same 
prediction.   
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found most of the corresponding residues in the yeast frataxin iron binding site (Ala 26, 
Asp 29, Glu 36, Asn 37, Ala 47 and Tyr 48 - based on Dfh numbering) lie on the helix-1 
and strand-2 portion of the molecule [5].   
 
4.5.3 Mapping the putative iron binding residues on Dfh  
NMR spectroscopy was used to identify frataxin amino acids that are influenced 
by the presence of ferrous iron.  A series of 1H-15N HSQC spectra were collected by 
titrating anaerobic ferrous ammonium sulfate at a final ratio of 1:1 protein to Fe(ll).  This 
ratio was in keeping with previously reported Isothermal Titration Calorimetry results, 
which showed that Dfh bound 1 atom of iron [8].  Both protein and Fe(ll) solutions were 
prepared under strict anaerobic conditions to prevent any chances of oxidation.  Data 
was collected under conditions identical to those of the backbone assignment 
experiments.  Our control apo-Dfh spectrum was identical to that obtained observed in 
Figure 4.4, enabling a direct comparison of the reproducible protein samples.  An 
overlay of backbone amide chemical shifts in the apo and holo forms revealed 10 
residues on Dfh underwent substantial chemical shift changes (Figure 4.7).  Residues 
that are shifted include D25, A26, E36, N37, D45, T54, V55, N56, H61 and E114.  In 
addition, residues that disappeared upon addition of iron include Y30, E33, S52, F88, 
G100, V103, and Y105, the disappearance is a possible indication of residues being in 
close proximity to the paramagnetic metal.  The positions on the apofrataxin structure 
that are affected by the presence of iron are shown in (Figure 4.8). 
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Figure 4.7.  Overlay of 2D 1H-15N HSQC spectra for Dfh. (Zoomed in for clarity).  Apo 
protein peaks are shown in red and holo protein peaks in blue.  Spectra were collected 
on a Varian Inova 600 MHz spectrometer at 25 0C in 20 mM HEPES (pH: 7.5) 150 mM 
NaCl and 5 mM β-mercaptoethanol.  Peaks that showed substantial chemical shift 
perturbations were identified by comparison to the map of assigned Dfh backbone 
resonances (Figure 4.4).  
 
	   	  
	   	   	  
124	  
                                      
Figure 4.8 Perturbed residues upon Fe (ll) titration into Dfh. Determined by 2D 1H-
15N HSQC NMR spectroscopy and modeled on PyMoL [36]. (A) Orientation 1 showing 
the helix-1and strand-1 acidic patch & (B) Orientation 2 showing the plane formed by 
helices & strands.  Residues that showed a perturbation upon iron addition (colored 
blue) include D25, A26, E36 and E37 on helix-1; D45 on strand-1; T54, V55 and N56 on 
strand-2; H61 on the strand 2, 3 loop and E114 on helix-2.  Residues that disappeared 
upon iron addition (colored red) include Y30, F31, E33 located on the helix-1 region; 
G43 on the helix, strand-1 loop; V46 and Y48 on strand-1; S52 on the strand 4, 5 loop 
and Q113 on helix-2. 
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4.6: Discussion: 
 
Similarity between frataxin orthologs and determinants of stability: 
All the characterized frataxins so far (Human, yeast, bacterial and fly) share a 
common structural fold comprising a characteristic α-β sandwich motif with a 
characteristic acidic patch in the region spanning helix-1 and strand-1 [21].  This region 
also contributes to the characteristic acidic pI of the protein: Dfh has a theoretical pI of 
4.65 which matches those of the human (4.98), yeast (4.34) and E. coli (4.24) proteins 
[6]. Surface exposed and charged residues in this acidic patch have been shown to be 
responsible for the iron binding properties of the Frataxin family [21].  
Although the structures are similar with a well folded globular C-terminus, the 
human and yeast proteins have been reported to be inherently unstable due to a high 
susceptibility to autodegradation.  One of the main reasons that contribute to 
autodegradation is the relatively long and unfolded N-terminal region, prior to helix-1.  
Both the yeast and human proteins have an 18 residue long N-terminus in the mature 
form [21] .  The function of this unfolded N-terminus is unclear.  In the human ortholog, it 
has been reported to function in binding Isu and also in binding iron [40, 41].  For Dfh, 
the presence of a mitochondrial targeting sequence has been reported [22] however; in 
vivo details of processing intermediates in the formation of mature Dfh are not yet 
available.  Our crystal structure spanning residues 65-190 of the open reading frame 
shows the presence of a relatively shorter N-terminus of 5 residues.  An additional 
structural feature that possibly contributes to the stability of Dfh is its long C-terminus, 
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which extends past helix-2, comprising 18 residues in length.  A longer C-terminus has 
been associated with a higher melting temperature and stability.  Thermal denaturation 
experiments have shown that Dfh melts at 590C, while the human and yeast orthologs 
melt at 600C and 440C respectively.  Human frataxin has a 16 residue spanning C-
terminus while yeast has only three residues.  However, the increased susceptibility of 
human frataxin’s N-terminus to autodegradation possibly contributes to its overall 
instability [21]. 
 
Iron binding properties of Drosophila Frataxin: 
Data was collected at a stoichiometry of 1:1 protein to iron in keeping with 
previous results from isothermal titration calorimetry [8]. Even at a 1:1 Fe:protein 
concentration, substantial chemical shift perturbations were observed, along with peak 
disappearance suggestive of residues in the vicinity of paramagnetic metal (see Figures 
4.7, 4.8).  Iron predominantly binds charged oxygen or nitrogen based amino acids, and 
to a lesser extent, thiols [6]. Most of these residues are located in the conserved helix-1, 
strand-1 acidic patch and are predominantly oxygen/nitrogen based, which fits well with 
our published XAS data on Dfh which shows Fe(ll) bound in an octahedral complex 
formed by oxygen/ nitrogen based ligands [8].  The resonance shifted residues are a 
good indicator of iron proximity, and on helix-1 the charged residues include Y30 and 
E33 were line broadened. Both these residues are solvent exposed indicating a possible 
role in iron binding.  An additional F31 was also line broadened possibly due to its 
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proximity to the above residues.  On strand-1, Y46 was line broadened, however not 
solvent exposed.  An additional charged residue that was line broadened is Q113 on 
helix-2.  Residues that were perturbed appear to flank the sides of the line broadened 
residues.  The occurrence of perturbed residues in clusters on helix-1 and on strand-1 
indicates the possibility of greater than one iron-binding site, as observed in the case of 
yeast frataxin which binds two iron atoms at sites located on helix-1 and strands-1& 2 
[5]. Human frataxin has been shown to bind up to 6 atoms of iron [42].  In addition, a 
cluster of residues in the region around the loops of strands-2 &3; strands-4 & 5 and the 
helix-2 could indicate a molecular rearrangement in structure as a result of metal 
binding or an additional metal binding site of a different functional significance. 
Experiments are currently underway to collect holo Dfh data at sub-stoichiometric and at 
higher concentrations to obtain more accurate information on residues that are shifted 
and stoichiometry of Fe (ll) binding.  A final confirmation of the possible iron binding 
sites would be site directed mutagenesis followed by tests for iron binding. 
 
Biological Significance: 
This study provides a complete description of the crystal structure of the 
Drosophila frataxin homolog (Dfh) from D. melanogaster.  In addition we completed 
backbone resonance assignments for Dfh residues using NMR.  These backbone 
assignments were used to determine putative residues involved in Fe (ll) binding.  Our 
studies show that Dfh is a well-folded protein with a fold similar to those of characterized 
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orthologs in the Frataxin family.  The monomeric form of the protein was used in all 
experiments and was shown to be able to bind iron, at sites that are predominantly 
located in the helix-1, strand-1 region just as in the case of the human and yeast 
frataxins indicating an iron chaperone role for Dfh is possible [21]. Though similar in its 
structure and function to related orthologs, Dfh appears to be far more stable against 
autodegradation.  Experiments are currently underway to map binding interfaces 
between Dfh & DIsu and additional binding partners. 
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CHAPTER 5 
SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
5.1 Significance of Iron in health: 
 
Iron is the most common transition metal in the earth’s crust and the most 
abundantly used transition metal among living organisms [1].  Its biological significance 
is largely attributed to its ability to undergo reversible oxidation-reduction chemistry that 
enables its participation in electron transfer reactions [2]. However, as a cofactor 
associated with proteins, its functions are not limited to electron transfer alone, but also 
include oxygen binding (hemoglobin) [3], catalysis (aconitase) [4], free-radical 
generation (SAM enzymes) [5] among many more.  Its versatility in function allows iron 
to participate in various processes that sustain life such as oxygen transport, oxidative 
metabolism, xenobiotic metabolism, ribonucleotide reduction during DNA synthesis, and 
for DNA repair [1, 2, 6].  Considering its biological significance, understanding its 
metabolism is crucial to maintaining a healthy population.  
As essential as it is for survival, iron in excess can be detrimental.  In the reaction 
described as ‘Fenton Chemistry’, ferrous iron participates in the generation of deadly 
hydroxyl radicals that can cause widespread damage to DNA, protein, membrane lipids 
and cellular constituents leading to cell death [7].  Iron-induced free radical damage has 
been implicated in the pathology of diseases of iron overload such as Friedreich’s 
Ataxia, a genetic disorder characterized by an accumulation of iron in actively 
metabolizing tissues ultimately leading to cardio- and neuro- degeneration and cell 
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death [8, 9].  In addition, neurodegenerative disorders such as Alzheimer’s and 
Parkinson’s disease are also associated with pathology caused by iron accumulation 
[10, 11].  At the other end of the spectrum, a deficiency of iron is associated with anemia 
[12] and has been reported to have deleterious effects on neurotransmission, 
myelination, and dopamine receptor and transporter functions [2].  Anemia is the most 
prevalent nutritional disorder worldwide, affecting about 30% of the world’s population 
according to the NIH.  In addition, we do not fully understand the role of iron in 
neurodegenerative disorders [13].  Therefore, iron metabolism has become an important 
research directive at national funding agencies.  
 
5.2 Summary & Future Directions 
Cellular iron metallochaperones are an important aspect of metal homeostasis.  
They are often small diffusible molecules that bind metal preventing any incidence of 
free radical generation [14].  The first chapter of my thesis is a review article that 
outlines the roles of two potential cellular iron chaperones, the mitochondrial iron 
chaperone Frataxin and the cytosolic PCBP family of proteins.  Frataxin plays a key role 
in iron homeostasis, evident from pathogenesis associated with the debilitating disease 
Friedreich’s Ataxia, described above, caused by an inability to synthesize this single 
protein.  Frataxin has been shown by numerous groups to be a part of the iron-sulfur 
cluster (ISC) multicomplex, where it functions in the capacity of a potential iron provider 
and an allosteric modulator of both the cysteine desulfurase and scaffold protein Isu [15-
	   	  
	   	   	  
136	  
17].  Other roles have been described, including an ability to oligomerize in the 
presence of oxygen and a ferroxidase ability that enables storage of ferric iron in a 
manner similar to ferritin [2, 7].  The role of frataxin needs to be clarified to assist in the 
development of improved research strategies for treating FRDA. 
The first chapter also outlines the role of the cytosolic PCBP family and describes 
its role in chaperoning iron to Ferritin for storage.  The iron binding and thermodynamic 
properties of PCPB have been established [18] but a structural characterization of the 
protein and residues involved in iron binding are still lacking.  Further clarification of the 
activity of the PCBP protein family will provide additional insight into cellular iron 
distribution strategies. 
The second and third chapters of my thesis are focused on understanding the 
initial events of iron loading onto the iron-sulfur cluster scaffold protein.  The second 
chapter describes the Fe(ll) binding properties of ISU using four orthologs (human, fly, 
yeast and from the thermophile Thermatoga).  By ITC, the ISU proteins were found to 
bind Fe(ll) with a nanomolar to micromolar affinity.  Using XAS, the Stemmler laboratory 
characterized the ISU-Fe(ll) bound complex in these orthologs and found that ISU 
appears to bind iron in a 6 coordinate oxygen/nitrogen ligand environment.  The 
absence of any thiol ligation to metal indicates iron loading onto ISU occurs at a site 
distinct from its cysteine rich active site.  These findings were confirmed by Mössbauer 
spectroscopy.  This would suggest that if Frataxin interacts with ISU to deliver iron, it 
may interact with the protein at this distinct metal-loading site.  
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The third chapter of my thesis builds off of the results of chapter 2 and is directed 
at elucidating the initial Fe(II) loading site on ISU, using the yeast model system.  The 
C-terminal helix of ISU has a high percentage of charged residues (approx. 50% based 
on the modeled structure of YIsu1) and appears to undergo an increase in order of fold 
upon substrate binding, similar to the transition demonstrated by the crystal structure of 
ISU in A. aeolicus [19].  Based on the crystal structure of E. coli IscU-IscS and 
predictive modeling of the Frataxin ortholog CyaY docking to the complex [20], the C-
terminus of IscU appears to be in a perfect orientation to bind CyaY and its charged 
surface would provide a complementary surface to Frataxin’s charged surface that has 
been implicated in iron binding and Isu interaction in yeast.  Yeast Isu1 residues E144A, 
and D145A and a double mutant E144A, D145A located on the protein’s C-terminal α-
helix, were mutated by site directed mutagenesis.  Among these, using competition 
assays, E144A, D145A and double mutants confirmed a drop in affinity for Fe(ll) at one 
site, while the affinity at the other site was only marginally decreased.  Binding of mutant 
proteins E144A and D145A to holo-Yfh1, measured by ITC followed an endothermic 
pattern of binding and was accompanied by a rise in enthalpy indicating an enthalpically 
unfavorable process.  Binding of holo-Yfh1 to WT YIsu1, on the other hand was an 
enthalpically favorable process.  This indicates that a mutation of the D145A residue 
perturbs the interaction between frataxin and YIsu1.  In addition, thermal denaturation 
experiments using DSC performed on holo WT YIsu1 was associated with a shift to 
higher temperature indicating a stabilizing change upon Fe(ll) binding.  In contrast, 
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however, the holo D145A mutant shifted to a lower temperature indicating 
destabilization upon iron binding.  Thermodynamics associated with denaturation of the 
holo forms of the mutant proteins were associated with a rise in enthalpy and entropy, 
while holo YIsu1 showed no significant change in associated thermodynamics 
compared to the apo form.  This possibly indicates that the stabilizing change in 
structure in WT YIsu1 balances changes in energetics upon binding Fe(ll).  The ability of 
YIsu1 WT and the D145A mutant to synthesize Fe-S clusters was also tested by an Fe-
S assembly assay using Near UV circular dichroism in the presence of either Fe(ll) or 
holo-Yfh1. WT YIsu1 showed a clear rise in activity in the presence of holo Frataxin 
compared Fe(ll) alone.  On the other hand, the D145A mutant showed a higher activity 
in the presence of Fe(ll) alone via a reaction that was slower than that in the presence of 
holo Yfh1, which was a reaction that appeared to reach saturation quickly.  This is 
consistent with the ITC results obtained with holo-Yfh1, which showed a weak binding of 
holo-Yfh1WT with D145A and thus, a weaker interaction.  In addition the mutant 
reaction with Yfh1WT possibly saturated faster due to a loss of an iron-binding site.  As 
iron binding is clearly facilitated by holo-Yfh1WT, in its absence, the mutant protein 
would take longer to bind iron and saturate the active site.  These results collectively 
indicate that the c-terminal charged residue D145A on Isu could be a possible ligand for 
holo frataxin interaction. 
An additional study that could further confirm that residues on YIsu1’s C-terminus 
are involved in frataxin binding is currently underway in the Stemmler laboratory, in 
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collaboration with Dr. Andrew Dancis (University of Pennsylvania).  Three constructs 
have been synthesized with a cleavable thrombin-His tag and with 10, 17 and 22 C-
terminal residues deleted.  Experiments are currently underway to determine which of 
these constructs show perturbations with frataxin binding.  Figure 5.1 shows an amino 
acid sequence alignment of these constructs after DNA isolation and sequencing.  
Obtaining a crystal structure of holo Yfh1WT and WT YIsu1 would be the final 
confirmation of the initial binding site.  Attempts, however, at crystallization have been 
plagued by poor stability of the yeast proteins and the redox activity of iron.  As an 
alternative method, the Drosophila proteins are also being tested for crystallization.  
Since Drosophila frataxin appears easily crystallizable, and, as we now have its crystal 
structure as a starting point, there is some indication that we may have the same 
success with DIsu. 
The final chapter of my thesis is a structural characterization of the Drosophila 
frataxin homolog Dfh.  Dfh was crystallized and the structure of the protein was 
determined by Dr. Joseph Brunzelle (APS, Argonne National Laboratories).  Like its 
yeast and human homologs, Dfh is well-folded with an α-β sandwich motif comprising 
two α-helices and six β-strands sandwiched between the two helices [21, 22].  The Dfh 
protein does not have a long unstructured N-terminal region like that seen in the yeast 
and human proteins [7, 23], and it has a considerably longer C-terminal tail; two factors 
that could contribute to its extraordinary stability.  Electrostatic potential surface plots 
show the presence of the conserved acidic patch at the α1-β1region on Dfh.  This acidic 
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Figure 5.1: Multiple sequence alignments of YIsu1 c-terminal truncation 
mutants after DNA isolation and sequencing: YIsu1 Δ10, Δ17 and Δ22 aligned 
with the YIsu1WT construct. 
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patch has been described to be important for the function of the frataxin proteins [7].  
15N HSQC experiments performed on Dfh in the presence of iron show that the majority 
of the perturbed residues lie on the α helix-1 and β-strands 1 & 2 region; this is in the 
region of the conserved acidic patch indicating an Fe chaperone role for Dfh.  Additional 
studies directed at characterizing the Dfh iron binding site involve collecting 1H-15N 
HSQC data upon titrating Fe(ll) into the protein at sub-stoichiometric and excess Fe to 
get insight into both residues that are perturbed and line broadened which would give an 
accurate estimate of the Fe binding site.  It will also provide some insight into 
stoichiometry, as upon excess Fe(ll) titration, protein aggregation alters the peak 
dispersion pattern.  As a future direction, mutation of these perturbed residues would be 
a good confirmation of their role in iron binding. 
Determining the structure of the multiprotein complex would provide real insight 
into how the complex functions.  This is a major goal of our lab, through collaboration 
with Dr. Amy Rosenzweig’s laboratory (Northwestern University).  As the Dfh protein 
has been found to be much more stable than its yeast and human counterparts, it would 
serve as a great starting point to attempt to crystallize the cysteine 
desulfurase/Isd11/Isu/Frataxin (SDUF) proteins in the Drosophila system considering 
the poor stability of the yeast proteins. 
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5.3 Conclusion 
One of the main goals of the Stemmler laboratory is to provide insight into role of 
the mitochondrial iron binding protein Frataxin in cellular iron homeostasis.  There is 
much speculation over the role of Frataxin as a possible iron chaperone for iron-sulfur 
cluster assembly.  Our work, along with others, have shown that Frataxin binds iron, 
and binds Isu, in a stable complex that appears to enhance iron-sulfur cluster assembly 
on Isu, a behavior consistent with that of a metal chaperone [15, 24, 25].  The bulk of 
my thesis was to characterize the initial Fe delivery site by Frataxin/Fe(II) acceptance 
site on Isu.  Residues on the C-terminus of Isu, upon mutagenesis to alanine, show a 
perturbation upon iron and holo-Yfh1WT binding.  A crystal structure would confirm 
these being the ligands of the 6-coordinate Isu-Fe (ll) complex determined by XAS.  In 
addition, this would reveal the residues that form the protein-protein interface.  This 
would serve as a good starting point for drug design of molecules that can mimic 
Frataxin’s activity as there is yet no cure for Friedreich’s Ataxia (FRDA) [8].  On the 
same note, the crystal structure of Dfh along with its extraordinary stability would serve 
as a good starting point for crystallization of holo Dfh-DIsu and holo SDUF. 
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Iron-induced free radical damage has been implicated in the pathology of diseases of 
iron overload such as Friedreich’s Ataxia, a genetic disorder characterized by an 
accumulation of iron in actively metabolizing tissues ultimately leading to cardio- and 
neuro- degeneration and cell death.  It is caused by an inability to synthesize the 
mitochondrial protein, frataxin.  Frataxin has been shown by numerous groups to be a 
part of the iron-sulfur cluster (ISC) multicomplex, where it functions in the capacity of a 
potential iron provider and an allosteric modulator of both the cysteine desulfurase and 
scaffold protein ISU.  My research has been focused on studying the interaction 
between frataxin and ISU, particularly the mechanism of iron binding/ iron acceptance 
by ISU from frataxin.  Using XAS, the Stemmler laboratory characterized the ISU-Fe(ll) 
bound complex in four orthologs and found that ISU appears to bind iron in a 6 
coordinate oxygen/nitrogen ligand environment.  The absence of any thiol ligation to 
metal indicates iron loading onto ISU occurs at a site distinct from its cysteine rich active 
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site.  Using site directed mutagenesis, followed by biochemical and biophysical analysis 
of the mutant proteins in the yeast system, we demonstrate that charged residues 
E144A and D145A possibly form the interface between iron loaded frataxin and ISU and  
are involved in initial iron acceptance by ISU. 
 
In this thesis, we also describe the crystal structure of Frataxin in D. 
melanogaster (Dfh).  Dfh is well-folded with an α-β sandwich motif comprising two α-
helices and six β-strands sandwiched between the two helices like its yeast and human 
homologs. The Dfh protein does not have a long unstructured N-terminal region like that 
seen in the yeast and human proteins and it has a considerably longer C-terminal tail; 
two factors that could contribute to its extraordinary stability.  15N HSQC experiments 
performed on Dfh in the presence of iron show that the majority of the perturbed 
residues lie on the α helix-1 and β-strands 1 & 2 region; this is in the region of the 
conserved acidic patch shared by frataxin proteins indicating an iron binding/ chaperone 
role for Dfh.  As the Dfh protein has been found to be much more stable than its yeast 
and human counterparts, it would serve as a great starting point to attempt to crystallize 
the cysteine desulfurase/Isd11/Isu/frataxin (SDUF) proteins in the Drosophila system 
considering the poor stability of the yeast proteins. 
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